| S.No. | GENERIC NAME | COMPOSITION | PH. REF | STRENGTH |
| 1 | Vildagliptin 50mg Tablets | Each uncoated tablet contains: Vildagliptin Excipients |
50mg qs | |
| 2 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film coated tablet contains: Vildagliptin Metformin Hydrochloride Excipients Colour: Titanium Dioxide IP & Iron Oxide Yellow |
IP | 50mg 500mg q.s. |
| 3 | Vildagliptin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Vildagliptin Metformin Hydrochloride Excipients Colour: Titanium Dioxide IP & Iron Oxide Yellow |
IP | 50mg 850mg q.s. |
| 4 | Vildagliptin & Metformin Hydrochloride Tablets | Each filmcoated tablet contains: Vildagliptin Metformin Hydrochloride Excipients Colour: Titanium Dioxide IP & Iron Oxide Yellow |
IP | 50mg 1000mg q.s. |
| 5 | Ofloxacin Tablet IP 200mg | Each Film Coated tablet Contains: Ofloxacin Excipients |
IP | 200 mg q.s. |
| 6 | Calcium & Vitamin D3 Tablet IP | Each Film Coated tablet Contains: Calcium Carbonate eq. to Elemental Calcium Vitamin D3 Excipients |
IP | 500 mg 250 IU q.s. |
| 7 | Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablet IP | Each Film Coated tablet Contains: Ferrous Ascorbate eq. to Elemental Iron Folic Acid Zinc Sulphate Monohydrate Excipients |
IP IP |
100 mg 1.5 mg 22.5 mg qs |
| 8 | Rabeprazole Sodium IP Tablet 20mg | Each Enteric Coated Tablets contains: Rabeprazole Sodium Excipients |
IP | 20 mg qs |
| 9 | Ofloxacin & Ornidazole Tablet IP 200mg | Each Film Coated tablet Contains: Ofloxacin Ornidazole Excipients |
IP IP |
200 mg 500 mg qs |
| 10 | Deflazacort Tablet | Each Uncoated Tablet Contains: Deflazacort Excipients |
6 mg qs | |
| 11 | Montelukast & Levocetrizine HCl Tablet IP | Each Film Coated Tablet Contains: Montelukast Sodium eq. to Montelukast Levocetrizine HCl Excipients |
IP IP |
10 mg 5 mg qs |
| 12 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains: Levofloxacin Hemihydrate eq. to Levofloxacin Excipients |
IP | 500 mg qs |
| 13 | Pantoprazole & Domperidone (SR) Tablets | Each Enteric Coated Tablet Contains: Pantoprazole Sodium Sesquihydrate Eq. to Pantoprazole Domperidone Excipients |
IP IP |
40 mg 10 mg qs |
| 14 | Metformin Hydrochloride Extended Tablet I.P. 500mg |
Each Uncoated Extended Release Tablets Contains: Metformin Hydrochloride Excipients Approved Colour Used |
IP | 500 mg qs |
| 15 | Glimepiride & Metformin HCl Tablet | Each Uncoted Bilayered Tablet Contains: Metformin Hydrochloride (as extended Release) Glimepiride Excipietns Approved colour used |
IP IP |
500 mg 1 mg qs |
| 16 | Glimepiride & Metformin HCl Tablet | Each Uncoted Bilayered Tablet Contains: Metformin Hydrochloride (as extended Release) Glimepiride Excipietns Approved colour used |
IP IP |
500 mg 2 mg qs |
| 17 | Aceclofenac & Thiocolchicoside Tablets | Each film coated tablet contains: Aceclofenac Thiocolchicoside Excipients Approved colour used |
IP IP |
100 mg 4 mg qs |
| 18 | Artemether & Lumefantrine tablets | Each film coated tablet contains: Artemether Lumefantrine Excipients Approved colour used |
IP IP |
80 mg 480 mg qs |
| 19 | Etoricoxib & Thocochicoside Tablets | Each film coated tablet contains: Etoricoxib Thocochicoside Excipients Approved colour used |
IP IP |
60 mg 4mg qs |
| 20 | Citicoline & Piracetam Tablets | Each film coated tablet contains: Citicoline Piracetam Excipients Approved colour used |
IP IP |
500 mg 400 mg qs |
| 21 | Etoricoxib Tablets IP 90 mg | Each film coated tablet contains: Etoricoxib Excipients Approved colour used |
IP | 90 mg qs |
| 22 | Etoricoxib Tablets IP 120 mg | Each film coated tablet contains: Etoricoxib Excipients Approved colour used |
IP | 120 mg qs |
| 23 | Fexofenadine Hydrochloride Tablets IP 120 mg | Each film coated tablet contains: Fexofenadine Hydrochloride Excipients Approved colour used |
IP | 120 mg. qs |
| 24 | Methylprednisolone Tablets IP 4 mg | Each uncoated tablet Contains: Methylprednisolone Excipients | IP | 4mg. qs |
| 25 | Methylprednisolone Tablets IP 8 mg | Each uncoated tablet Contains: Methylprednisolone Excipients | IP | 8 mg qs |
| 26 | Methylprednisolone Tablets IP 16 mg | Each uncoated tablet Contains: Methylprednisolone Excipients | IP | 16 mg qs |
| 27 | Linezolid Tablets IP 600 mg | Each film coated tablet contains: Linezolid Excipients Approved Colour Used |
IP | 600mg qs |
| 28 | Clarithromycin Tablets IP 250 mg | Each film coated tablet contains: Clarithromycin Excipients Approved colour used |
IP | 250mg qs |
| 29 | Clarithromycin Tablets IP 500 mg | Each film coated tablet contains: Clarithromycin Excipients Approved colour used |
IP | 500mg qs |
| 30 | Pantoprazole Gastro-Resistant Tablets IP 40 mg | Each Enteric Coated Tablet Contains: Pantoprazole Sodium Sesquihydrate Eq. to Pantoprazole Excipients |
IP | 40 mg. qs |
| 31 | Paracetamol Tablets IP 650 mg | Each uncoated Tablet Contains: Paracetamol Excipients |
IP | 650 mg qs |
| 32 | Diclofenac Sodium & Paracetamol Tablets | Each uncoated tablet contains: Diclofenac Sodium Paracetamol Excipients Approved colour used |
IP IP |
50 mg 325 mg qs |
| 33 | Paracetamol Tablets IP 500 mg | Each uncoated Tablet Contains: Paracetamol Excipients |
IP | 500 mg qs |
| 34 | Albendazole Tablets IP 400 mg | Each chewable uncoated tablet contains: Albendazole Excipients |
IP | 400 mg qs |
| 35 | Glimepiride Tablet IP 1mg | Each uncoated tablet contains: Glimepiride Excipients Approved colour used. |
IP | 1mg qs |
| 36 | Glimepiride Tablet IP 2mg | Each uncoated tablet contains: Glimepiride Excipients Approved colour used. |
IP | 2mg qs |
| 37 | Fluconazole Tablets IP 150 mg | Each uncoated tablet contains: Fluconazole Excipients |
IP | 150 mg qs |
| 38 | Atorvastatin Calcium Tablet IP 10 mg | Each film coated tablet contains: Atorvastatin Calcium Eq. to Atorvastatin Excipients Approved colour used |
IP | 10mg qs |
| 39 | Atorvastatin Calcium Tablet IP 20 mg | Each film coated tablet contains: Atorvastatin Calcium Eq. to Atorvastatin Excipients Approved colour used |
IP | 20 mg qs |
| 40 | Telmisartan Tablets IP 40 mg | Each film coated tablet contains: Telmisartan Excipients Approved colour used |
IP | 40 mg qs |
| 41 | Telmisartan Tablets IP 20 mg | Each film coated tablet contains: Telmisartan Excipients Approved colour used |
IP | 20mg qs |
| 42 | Levocetirizine Hydrochloride Tablets IP 5mg | Each uncoated tablet contains: Levocetirizine Hydrochloride Excipients Approved colour used. |
IP | 5mg qs |
| 43 | Rosuvastatin Calcium Tablet IP 10 mg | Each film coated tablet contains: Rosuvastatin Calcium Eq. to Rosuvastatin Excipients |
IP | 10 mg qs |
| 44 | Rosuvastatin Calcium Tablet IP 20 mg | Each film coated tablet contains: Rosuvastatin Calcium Eq. to Rosuvastatin Excipients |
IP | 20mg qs |
| 45 | Azithromycin Tablets IP 500 mg | Each film coated tablet contains: Azithromycin Dihydrate eq. to Azithromycin Excipients |
IP | 500 mg qs |
| 46 | Azithromycin Tablets IP 250 mg | Each film coated tablet contains: Azithromycin Dihydrate eq. to Azithromycin Excipients |
IP | 250 mg qs |
| 47 | Ondansetron Tablets IP 4 mg | Each uncoated tablet contains: Ondansetron Hydrochloride Eq. to Ondansetron Excipients | IP | 4mg. qs |
| 48 | Diclofenac Potassium & Serratiopeptidase Tablets | Each film coated tablet contains: Diclofenac Potassium Serratiopeptidase (as enteric coated granules) Excipients |
BP IP | 50 mg 10 mg qs |
| 49 | Aceclofenac & Paracetamol Tablets | Each uncoated tablet contains: Aceclofenac Paracetamol Excipients Approved colour used |
IP IP |
100 mg 325 mg qs |
| 50 | Montelukast 10mg & Fexofenadine Chewable Tablet IP | Each Uncoated chewable tablet conains: Montelukast Sodium eq. to Montelukast Fexofenadine Hydrochloride Excipients |
IP IP |
10 mg 120 mg qs |
| 51 | Voglibose & Metformin Hydrochloride Tablets | Each uncoated tablet contains: Voglibose Metformin Hydrochloride Excipients |
IP IP |
0.2 mg 500 mg qs |
| 52 | Voglibose & Metformin Hydrochloride Tablets | Each uncoated tablet contains: Voglibose Metformin Hydrochloride Excipients |
IP IP |
0.3 mg 500 mg qs |
| 53 | Nimesulide & Paracetamol Tablets | Each Uncoated tablet contains: Nimesulide Paracetamol Excipients |
IP IP |
100 mg 325 mg qs |
| 54 | Ivermectin & Albendazole Tablets | Each uncoated tablet contains: Ivermectin Albendazole Excipients |
IP IP |
6 mg. 400 mg qs |
| 55 | Calcitriol, Calcium with Zinc Sulphate Tablet | Each film coated tablet contains: Calcitriol Calcium Carbonate Eq. to elemental Calcium Zinc Sulphate Monohydrate Eq. to elemental Zinc Excipients Approved color used |
IP IP IP |
0.25mg 1000mg 400mg 7.5mg q.s. |
| 56 | Gabapentin & Methylcobalamin Tablets | Each film coated tablet contains: Gabapentin Methylcobalamin Excipients Approved colour used |
IP IP |
300 mg 500 mcg qs. |
| 57 | Doxycycline Hyclate Tablets | Each film coated tablet contains: Doxycycline Hyclate eq. to Doxycycline (in a beta Cyclodextrine base) Excipients |
IP | 100mg qs |
| 58 | Ferrous Ascorbate & Folic Acid Tablet | Each Film Coated tablet Contains: Ferrous Ascorbate eq. to Elemental Iron Folic Acid Excipients |
IP | 100 mg 1.5 mg qs. |
| 59 | Aceclofenac Sustained Release Tablet | Each film coated sustained release tablet contains: Aceclofenac Approved color used |
IP | 200 mg q.s. |
| 60 | Levocetirizine Hydrochloride & Ambroxol Hydrochloride Tablets | Each film coated tablet contains: Levocetirizine Hydrochloride Ambroxol Hydrochloride (in sustained release form) Excipients |
IP IP |
5 mg 75 mg qs |
| 61 | Pantoprazole Sodium & DomperidoneTablets | Each enteric coated tablet contains: Pantoprazole Sodium Eq. to Pantoprazole Domperidone Excipients Approved colour used |
IP IP |
20 mg 10 mg qs |
| 62 | Divalproex Sodium Prolong Release tablets | Each film coated prolong release tablet contains: Divalproex Sodium eq. to Valporic Acid Excipients Approved colour used. |
IP | 500 mg qs. |
| 63 | Divalproex Sodium Prolong Release tablets | Each film coated prolong release tablet contains: Divalproex Sodium eq. to Valporic Acid Excipients |
IP | 750 mg qs |
| 64 | Duloxetine Gastro-resistant tablet IP | Each enteric coated tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients Approved colour used |
IP | 20 mg qs |
| 65 | Voglibose Tablet IP | Each uncoated tablet contains: Voglibose Excipients |
IP | 0.2mg qs |
| 66 | Voglibose Tablet IP | Each uncoated tablet contains: Voglibose Excipients |
IP | 0.3 mg qs. |
| 67 | Amlodipine Besylate & Atenolol Tablets | Each uncoated tablet contains: Amlodipine Besylate Eq. to Amlodipine Atenolol Excipients |
IP IP |
5 mg 50 mg qs. |
| 68 | Tranexamic & Mefenamic Acid Tablets | Each film coated Tablet contains: Tranexamic Mefenamic Acid Excipients Approved colour used |
IP IP |
500 mg 250 mg q.s. |
| 69 | Clopidogrel Bisulphate & Aspirin Tablets | Each uncoated bilayred tablet contains: Clopidogrel Bisulphate Eq. to Clopidogrel Aspirin (as enteric coated tablets) Excipients Approved colour used |
IP IP |
75 mg 150 mg qs. |
| 70 | Lornoxicam & Paracetamol Tablets | Each film coated tablet contains: Lornoxicam Paracetamol Excipients Approved colour used |
IP IP |
4 mg 325 mg qs |
| 71 | Lornoxicam Tablets | Each film coated tablet contains: Lornoxicam Excipients Approved colour used |
IP | 4mg qs |
| 72 | Isoxsuprine Hydrochloride Tablets IP | Each film coated tablet contains: Isoxsuprine Hydrochloride Excipients Approved colour used |
IP | 20 mg. qs |
| 73 | Isoxsuprine Hydrochloride Tablets IP | Each film coated tablet contains: Isoxsuprine Hydrochloride Excipients Approved colour used |
IP | 40 mg. qs |
| 74 | Piracetam Tablets IP | Each film coated tablet contains: Piracetam Excipients Approved colour used. |
IP | 800mg qs |
| 75 | Alfuzosin Hydrochloride Tablet IP | Each film coated extended release tablet contains Alfuzosin Hydrochloride Excipients Approved colour used |
IP | 10 mg qs. |
| 76 | Etodolac Tablet IP | Each film coated tablet contains: Etodolac Excipients Approved Colour used |
IP | 400 mg qs |
| 77 | Metoprolol Succinate Extended Release Tablets IP | Each uncoated Extended Release Tablets Contains Meroprolol Succinate Excipients Approved Colour used |
IP | 50 mg qs. |
| 78 | Montelukast & Levocetirizine Tablets IP | Each Disperisible Uncoated Tablet Contains: Montelukast Sodium eq. to Montelukast Levocetirizine Hydrochloride Excipients |
IP IP |
5 mg 2.5 mg qs. |
| 79 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: Ursodeoxycholic Acid Excipients | IP | 150 mg qs |
| 80 | Montelukast Sodium Tablet IP | Each uncoated tablet contains: Montelukast Sodium eq. to Montelukast Excipients |
IP | 10 mg qs |
| 81 | Betahistine Dihydrochloride Tablets IP | Each Film coated tablet contains: Betahistine Dihydrochloride Excipients |
IP | 8 mg qs |
| 82 | Betahistine Dihydrochloride Tablets IP | Each Film coated tablet contains: Betahistine Dihydrochloride Excipients |
IP | 16 mg qs |
| 83 | Carbamazepine Controlled Release Tablets | Each uncoated controlled release tablet contains: Carbamazepine Excipients |
IP | 200 mg q.s. |
| 84 | Gliclazide Tablets IP | Each uncoated tablet contains : Gliclazide Excipients | IP | 40 mg qs |
| 85 | Gliclazide & Metformin Hydrochloride Tablets IP | Each film coated tablet contains : Gliclazide Metformin hydrochloride (extended release) Excipients | IP IP |
80 mg 500 mg qs. |
| 86 | Sildenafil Citrate Tablets IP | Each film coated tablet contains: Sildenafil Citrate eq. to Sildenafil excipients Approved Colour used |
IP | 50 mg. qs |
| 87 | Sildenafil Citrate Tablets IP | Each film coated tablet contains: Sildenafil Citrate eq. to Sildenafil excipients Approved Colour used |
IP | 100 mg. qs. |
| 88 | Atorvastatin Calcium & Fenofibrate tablets | Each film coated tablet contains: Atorvastatin Calcium eq. to Atorvastatin Fenofibrate Excipients Approved colour used |
IP IP |
10 mg 160 mg qs |
| 89 | Baclofen Tablets IP | Each uncoated tablet contains: Baclofen Excipients Approved colour used |
IP | 10 mg qs |
| 90 | Ursodeoxycholic Acid Tablets IP | Each uncoated tablet contains: Ursodeoxycholic Acid Excipients | IP | 300 mg qs |
| 91 | Diacerein with Glucosamine Sulphate, Potassium Chloride & Methylsulfonyl Methane Tablets | Each film coated tablet contains: Diacerein Glucosamine Sulphate Potassium Chloride (eq. to Glucosamine 471 mg.) Methyl Sulfonyl Methane Excipients Approved colour used |
IP USP USP |
50 mg 750 mg 250 mg. qs. |
| 92 | Lornoxicam & Paracetamol Tablets | Each film coated tablet contains: Lornoxicam Paracetamol excipients Approved colour used |
IP IP |
8 mg 325 mg qs |
| 93 | Divalproex Sodium Prolong Release tablets | Each film coated prolong release tablet contains: Divalproex Sodium eq. to Valporic Acid Excipients |
IP | 250 mg qs |
| 94 | Baclofen Tablets IP | Each uncoated tablet contains: Baclofen Excipients Approved colour used |
IP | 20 mg qs |
| 95 | Piracetam & Citicoline Tablets IP | Each film coated tablet contains: Piracetam Citicoline Excipients Approved colour used |
IP IP |
800 mg 500 mg qs. |
| 96 | Deflazacort Tablet | Each uncoated tablet contains: Deflazacort Excipients Approved coour used |
12 mg qs | |
| 97 | Gabapentin Tablets IP | Each film coated tablet contains: Gabapentin Excipients Approve colour used |
IP | 100 mg. qs. |
| 98 | Mecobalamin Tablets | Each film coated tablet contains Mecobalamin Excipients | IP | 1500 mcg qs |
| 99 | Doxofylline Tablets | Each uncoated tablet contains: Doxofylline Excipients | IP | 400 mg qs |
| 100 | Esomeprazole Magnesium Tablet I.P. | Each Enteric Coated Tablets contains: Esomeprazole Magnesium Eq. to Esomeprazole Excipients |
IP | 40 mg qs |
| 101 | Olanzapine Tablets IP | Each film coated tablet contains Olanzapine Excipients Approved color used |
IP | 2.5 mg qs. |
| 102 | Olanzapine Tablets IP | Each film coated tablet contains Olanzapine Excipients Approved color used |
IP | 5 mg qs |
| 103 | Olanzapine Tablets IP | Each film coated tablet contains Olanzapine Excipients Approved color used |
IP | 7.5 mg qs |
| 104 | Olanzapine Tablets IP | Each film coated tablet contains Olanzapine Excipients Approved color used |
IP | 10 mg qs |
| 105 | Losartran Potassium & Hydrochlorothiazide Tablets IP | Each film coated tablet contains: Losartran Potassium Hydrochlorothiazide Excipients |
IP IP |
50 mg 12.5 mg qs. |
| 106 | Tamsulosin Hydrochloride Prolong Release Tablets IP | Each film Prolong release coated tablet contains: Tamsulosin Hydrochloride Excipients | IP | 0.4 mg. qs |
| 107 | Pyridoxine & Doxylamine Succinate Tablets | Each film coated tablet contains: Pyridoxine HCl Doxylamine Succinate Excipients Approved colou used |
IP | 20 mg 20 mg qs |
| 108 | Metoprolol Tartrate Extended Release Tablets | Each Uncoated extended release tablet contains: Metoprolol Tartrate Excipients | IP | 25 mg qs. |
| 109 | Tamsulosin Hydrochloride & Dutasteride Tablets | Each film coated tablet contains Tamsulosin Hydrochloride (E.R.) Dutasteride Excipients | IP IP |
0.4 mg 0.5 mg qs. |
| 110 | Glimepiride & Metformin HCl Tablet IP | Each uncoated bilayred tablet contains: Metformin Hydrochloride (as extended release) Glimepiride Excipients Approved colour used |
IP IP |
1000 mg 1 mg. qs. |
| 111 | Glimepiride & Metformin HCl Tablet IP | Each uncoated bilayred tablet contains: Metformin Hydrochloride (as extended release) Glimepiride | IP IP |
1000 mg 2 mg. |
| 112 | Ibandronic Acid Tablets IP | Each uncoated tablet contains Ibandronic Acid Excipients | 150 mg qs. | |
| 113 | Telmisartan & Hydrochlorothiazide Tablets IP | Each film coated tablet contains Telmisartan Hydrochlorothiazide Excipients Approved colour used |
IP IP |
40 mg 12.5 mg qs |
| 114 | Tizanidine Hydrochloride Tablets IP | Each uncoted tablet contains: Tizanidine Hydrochloride Excipients | IP | 2 mg qs |
| 115 | Flunarizine Hydrochloride Tablets | Each uncoated tablet contains: Flunarizine Hydrochloride eq. to Flunarizine Excipients |
BP | 10 mg qs. |
| 116 | Levetiracetam Tablets IP | Each film coated tablets contains: Levetiracetam Excipients |
IP | 500 mg. qs |
| 117 | Levetiracetam Tablets IP | Each film coated tablets contains: Levetiracetam Excipients |
IP | 750 mg qs |
| 118 | Ketorolac Tromethamine Tablets I.P. | Each uncoated tablet contains: Ketorolac Tromethamine Excipients |
IP | 10 mg qs |
| 119 | Domperidone Tablets IP | Each uncoated tablet contains: Domperidone Maleate Eq. to Domperidone |
IP | 10 mg qs |
| 120 | Tizanidine Hydrochloride Tablets IP | Each uncoated tablet contains Tizanidine Hydrochloride Excipients | IP | 4.0 mg qs |
| 121 | Citicoline Sodium Tablet IP | Each film coated tablet contains Citicoline Sodium eq. to Citicoline Excipients |
IP | 500 mg qs. |
| 122 | Serratiopeptidase Tablets IP | Each film coated tablet contains Serratiopeptidase (Enzyme Activity 2000 units) Excipients |
Ip | 10 mg qs |
| 123 | Rifaximin Tablets | Each film coated tablets contains: Rifaximin Excipients Approved colour used |
BP | 200 mg q.s. |
| 124 | Rifaximin Tablets | Each film coated tablets contains: Rifaximin Excipients Approved colour used |
BP | 400 mg qs |
| 125 | Rifaximin Tablets | Each film coated tablets contains: Rifaximin Excipients Approved colour used |
BP | 550 mg qs. |
| 126 | Lansoprazole Gastro-Resistant Capsules IP | Each hard gelatin capsules contains Lansoprazole (enteric coated pellets) excipients Approved colour used |
IP | 30 mg qs |
| 127 | Voriconazole Tablets IP | Each film coated tablets contains Voriconazole Excipients |
IP | 200 mg q.s. |
| 128 | Drotaverine HCl & Mefenamic Acid Tablets | Each film coated tablets contains Drotaverine HCl Mefenamic Acid Excipients Approved colour used. |
IP IP |
80 mg 250 mg. qs. |
| 129 | Febuxostat Tablets | Each uncoated tablets contains: Febuxostat Approved colour used | 40 mg | |
| 130 | Aciclovir Tablets IP | Each uncoated tavlets contains Aciclovir Excipients approved colour used |
IP | 400 mg qs |
| 131 | Sevelamer Carbonate Tablets | Each film coated tablets contains Sevelamer Carbonate excipients |
800 mg qs | |
| 132 | Terbinafine Tablets IP | Ech film coated tablets contains Terbinafine HCl eq. to Terbinafine Excipients |
IP | 250 mg qs |
| 133 | Sevelamer Carbonate Tablets | Each film coated tablets contains Sevelamer Carbonate excipients |
IP | 400 mg qs |
| 134 | Rosuvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: Rosuvastatin Calcium Fenofibrate (micronized) Excipients Approved colour used | IP IP |
10 mg 160 mg qs |
| 135 | Nicorandil Tablets IP | Each uncoated tablets contains: Nicorandil Excipients | IP | 5 mg qs |
| 136 | Nicorandil Tablets IP | Each uncoated tablets contains: Nicorandil Excipients | IP | 10 mg qs. |
| 137 | Nicorandil Tablets IP | Each uncoated tablets contains: Nicorandil Excipients | IP | 20 mg qs |
| 138 | Ondansetron Tablets IP | Each uncoated tablets contains: Ondansetron HCl eq. to Ondansetrom excipients |
IP | 8 mg qs |
| 139 | Hydroxyzine HCl Tabelts IP | Each uncoated tablets contains Hydroxyzine HCL | IP | 10 mg qs |
| 140 | Hydroxyzine HCl Tabelts IP | Each uncoated tablets contains Hydroxyzine HCL | IP | 25 mg qs. |
| 141 | Tranexamic Acid Tablets IP | Each film coated tablet contains Tranexamic Acid Excipients |
IP | 500 mg qs |
| 142 | Folic Acid Tablets IP | Each film coated tablets contains Folic Acid Excipients Approved colour used |
IP | 5 mg qs |
| 143 | Folic Acid Tablets IP | Each film coated tablets contains Folic Acid Excipients Approved colour used |
IP | 10 mg qs |
| 144 | Folic Acid & Methylcobalamin Tablets IP | Each film coated tablets contains Folic Acid Methylcobalamin Excipients Approved colour used |
IP IP |
5 mg 750 mcg qs |
| 145 | Ofloxacin Tablets IP | Each film coated tablet contains Ofloxacin excipients Approved colour used |
IP | 400 mg qs |
| 146 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains Levofloxacin Hemihydrate eq. to Levofloxacin Excipients Approved colour used |
IP | 250 mg qs |
| 147 | Ciprofloxacin Tablets IP | Each film coated tablets contains Ciprofloxacin HCl eq. to Ciprofloxacin Excipients |
IP | 500 mg qs |
| 148 | Pregabalin & Methylcobalamin Tablets | Each film coated tablets contains: Pregabalin (Sustained release) Methylcobalamin Excipients Approved colour used | IP | 150 mg 1500 mcg qs |
| 149 | Ranolazine extended Release Tablets | Each film coated tablet contains Ranolazine (As extended Release) Excipients Approved colour used | 500 mg qs | |
| 150 | Calcium, Calcitriol & Zinc Sulphate Tablets | Each film coated tablets contains: Calcium Citrate Maleate eq. to Elemental Calcium Calcitriol Zinc sulphate Monohydrate eq. to Elemental Zinc excipients Approved colour used |
IP IP IP |
200 mg 0.25 mcg 7.5 mg qs |
| 151 | Cetirizine Hydrochloride Tablets IP | Each film coated tablet contains: Cetirizine HCl Excipients Approved colour used |
IP | 10 mg qs |
| 152 | Desloratadine Tablets | Each film coated tablets contains: Desloratadine Approved colour used |
5mg | |
| 153 | Desloratadine & Montelukast Tablets | Each film coated tablets contains Desloratadine Montelukast Sodium eq. to Montelukast Excipients |
IP IP |
5mg 10mg q.s. |
| 154 | Roxithromycin Tablets IP | Each film coated tablet contains: Roxithromycin Approved colour used |
IP | 150mg |
| 155 | Ramipril Tablets IP | Each film coated tablet contains Ramipril Excipients |
IP | 10 mg qs |
| 156 | Ramipril Tablets IP | Each film coated tablet contains: Ramipril Excipients |
IP | 5 mg qs |
| 157 | Ramipril Tablets IP | Each film coated tablet contains Ramipril Excipients Approved colour used |
IP | 2.5 mg qs |
| 158 | Ramipril & Hydrochlothiazide Tablets | Each film coated tablet contains Ramipril Hydrochlothiazide Excipients Approved colour used |
IP IP |
5 mg 12.5 mg qs |
| 159 | Cholecalciferol Tablets IP | Each film coated tablet Contains Cholecalciferol Excipients |
IP | 0.25 mg qs |
| 160 | Cholecalciferol Tablets IP | Each film coated tablets Contains Cholecalciferol Excipients |
IP | 1 mg qs |
| 161 | Magaldrate & Simethicone Tablets | Each Chewable tablet contains Magaldrate Simethicone Excipients |
IP IP |
400 mg 60 mg qs |
| 162 | Mefenamic Acid & Dicylomine Hydrochloride Tablets IP | Each Uncoated Tablets contains: Mefenamic Acid Dicylomine Hydrochloride Excipients Approved colour used |
IP IP |
250 mg 10 mg qs |
| 163 | Torsemide Tablets IP | Each Uncoated Tablets contains Torsemide Excipients |
IP | 20 mg qs |
| 164 | Torsemide Tablets IP | Each Uncoated Tablets contains Torsemide | IP | 10 mg |
| 165 | Doxofylline & Terbutaline Sulphate Tablets | Each uncoated tablet contains Doxofylline Terbutaline Sulphate Excipients Approved colour used | IP IP |
400mg 5mg qs |
| 166 | Cyclobenzaprine Tablets IP | Each uncoated tablet contains Cyclobenzaprine Excipients |
IP | 10mg qs |
| 167 | Cyclobenzaprine Tablets IP | Each uncoated tablet contains Cyclobenzaprine Excipients |
IP | 5mg |
| 168 | Loratadine Tabelts U.S.P. | Each uncoated tablet contains Loratadine Excipients Approved colour used |
USP | 10mg qs |
| 169 | Teneligliptin Tablets IP | Each film coated tablet contains Teneligliptin Hydrobromide Hydrate eq. to Teneligliprin Excipients | IP | 20mg qs |
| 170 | Oxcarbazepine Tablets IP | Each uncoated tablet contains Oxcarbazepine Excipients | IP | 300mg qs |
| 171 | Olopatadine Tablets IP | Each uncoated tablet contains Olopatadine Hydrochloride | IP | 5mg qs |
| 172 | Tolperisone HCl Tablets | Each film coated tablet contains Tolperisone HCL Excipients |
150mg qs | |
| 173 | Clomifene Tablets IP | Each uncoated tablet contains Clomifene Citrate | IP | 50mg qs |
| 174 | Clomifene Tablets IP | Each uncoated tablet contains Clomifene Citrate | IP | 25mg qs |
| 175 | Levamisole Hydrochloride Tablets IP | Each film coated tablet contains Levamisole Hydrochloride eq. to Levamisole Excipients Approved colour used |
IP | 150mg qs |
| 176 | Levamisole Hydrochloride Tablets IP | Each film coated tablet contains Levamisole Hydrochloride eq. to Levamisole Excipients Approved colour used |
IP | 50mg qs |
| 177 | Thyroxine Tablets IP | Each uncoated tablet contains Thyroxine Sodium eq. to Thyroxine Sodium excipients |
IP | 12.5mc g qs |
| 178 | Thyroxine Tablets IP | Each uncoated tablet contains Thyroxine Sodium eq. to Thyroxine Sodium |
IP | 25mcg qs |
| 179 | Thyroxine Tablets IP | Each uncoated tablet contains Thyroxine Sodium eq. to Thyroxine Sodium |
IP | 50mcg qs |
| 180 | Thyroxine Tablets IP | Each uncoated tablet contains Thyroxine Sodium eq. to Thyroxine Sodium |
IP | 75mcg qs |
| 181 | Thyroxine Tablets IP | Each uncoated tablet contains Thyroxine Sodium eq. to Thyroxine Sodium |
IP | 100mcg qs |
| 182 | Finasteride Tablets IP | Each film coated tablet contains Finasteride Excipients Approved colour used |
IP | 5mg qs |
| 183 | Diclofenac Potassium & Metaxalone Tablets | Each film coated tablet contains Diclofenac Potassium Metaxalone Excipients Approved colour used |
BP | 50mg 400mg qs |
| 184 | Flavoxate Tablets IP | Each film coated tablet contains Flavoxate Hydrochloride Excipients Approved colour used |
IP | 200mg qs |
| 185 | Ferrous Bisgylcinate, Folic Acid, Zinc Bisgycinate & Mecobalamin Tablets | Each film coated tablet contains Ferrous Bisglycinate eq. to Elemental Iron Folic Acid Zinc Bisglycinate eq. to Elemental Zinc Mecobalamin Excipients Approved colour used |
IP IP |
60mg 1.0mg 15mg 500mcg qs |
| 186 | Trioxsalen Tablets U.S.P. | Each film coated tablet contains Trioxsalen Excipients Approved colour used |
USP | 5mg qs |
| 187 | Trioxsalen Tablets U.S.P. | Each film coated tablet contains Trioxsalen Excipients Approved colour used |
USP | 10mg qs |
| 188 | Trioxsalen Tablets U.S.P. | Each film coated tablet contains Trioxsalen Excipients Approved colour used |
USP | 25mg qs |
| 189 | Doxepin Tablets | Each film coated tablet contains Doxepin Hydrochloride eq. to Doxepin Excipients Approved colour used |
IP | 10mg qs |
| 190 | Doxepin Tablets | Each film coated tablet contains Doxepin Hydrochloride eq. to Doxepin Excipients Approved colour used |
IP | 25mg qs |
| 191 | Doxepin Tablets | Each film coated tablet contains Doxepin Hydrochloride eq. to Doxepin Excipients Approved colour used |
IP | 50mg qs |
| 192 | Zinc Sulphate Dispersible Tablets IP | Each uncoated dispersible tablet contains Zinc Sulphate Monohydrate eq. to elemental Zinc Excipients Approved colour used |
IP | 20mg qs |
| 193 | Azathioprine Tablets IP | Each film coated tablet contains Azathioprine Excipients Approved colour used |
IP | 50mg qs |
| 194 | Hydroxychloroquine Sulphate Tablets IP | Each film coated tablets contains Hydroxychloroquine Sulphate Excipients Approved colour used | IP | 200mg qs |
| 195 | Etodolac & Thiocolchicoside Tablets | Each film coated tablet contains Etodolac Thiocolchicoside Excipients Approved colour used |
IP IP |
300mg 4mg qs |
| 196 | Mefenamic Acid Tablets BP | Each uncoated tablet contains Mefenamic Acid Excipients |
IP | 500mg qs |
| 197 | Mefenamic Acid Tablets BP | Each uncoated tablet contains Mefenamic Acid Excipients |
IP | 250mg qs |
| 198 | Etodolac Prolong Release Tablets IP | Each film coated prolong release tablet contains Etodolac Excipients |
IP | 600mg qs |
| 199 | Calcium, Magnesium, Zinc & Vitamin D3 Tablets | Each film coated tablet contains: Calcium Citrate Magnesium Hydrochloride eq. to Elemental Magnesium Zinc Sulphate eq. to Elemental Zinc Vitamin D3 Excipients Approved colour used |
USP IP IP IP |
1000mg 100mg 4mg 200 I.U. q.s. |
| 200 | Etoricoxib & Paracetamol Tablets | Each film coated tablet contains Etoricoxib Paracetamol Excipients Approved colour used |
IP IP |
60mg 325mg qs |
| 201 | Amlodipine Tablets IP | Each uncoated tablet contains: Amlodipine Besilate eq. to Amlodipine Excipients | IP | 5 mg qs. |
| 202 | Amlodipine Tablets IP | Each uncoated tablet contains: Amlodipine Besilate eq. to Amlodipine Excipients | IP | 10 mg qs. |
| 203 | Artemether & Lumefantrine Dispersible tablets | Each uncoated dispersible tablet contains Artemether Lumefantrine Excipients Approved colour used |
IP IP |
20 mg 120 mg qs |
| 204 | Artemether & Lumefantrine Dispersible tablets | Each uncoated dispersible tablet contains Artemether Lumefantrine Excipients Approved colour used |
IP IP |
40 mg 240 mg qs |
| 205 | Ciprofloxacin & Tinidazole Tablets | Each film coated tablet contains Ciprofloxacin HCl Eq. to Ciprofloxacin Tinidazole Excipients Approved colour used |
IP IP |
500mg 600mg q.s. |
| 206 | Febuxostat Tablets | Each film coated tablets contains: Febuxostat Excipients Approved colour used |
40 mg | |
| 207 | Febuxostat Tablets | Each film coated tablets contains: Febuxostat Excipients Approved colour used |
80 mg | |
| 208 | Fluconazole Dispersible Tablets | Each uncoated Dispersible tablet contains Fluconazole Excipients |
IP | 50 mg qs |
| 209 | Levocetirizine HCl Tablet IP | Each film coated tablet contains Levocetirizine Dihydrochloride Excipients Approved colour used |
IP | 5mg qs |
| 210 | Levocetirizine HCl Tablet | Each film coated tablet contains Levocetirizine Dihydrochloride Excipients Approved colour used |
IP | 10mg qs |
| 211 | Levofloxacin & Ambroxol Tablets | Each uncoated bilayered tablet contains Levofloxacin Hemihydrate eq. to Levofloxacin Ambroxol Tablets (In sustained release form) Excipients Approved coloue used |
IP IP |
500mg 75mg qs |
| 212 | Lornoxicam Tablets | Each film coated tablet contains Lornoxicam Excipients Approved colour used |
8mg qs | |
| 213 | Losartan Potassium Tablets | Each film coated tablets contains Losartan Potassium Excipients |
IP | 25mg qs |
| 214 | Losartan Potassium Tablets IP | Each film coated tablets contains Losartan Potassium Excipients |
IP | 50mg qs |
| 215 | Norfloxacin & Tinidazole tablets | Each film coated tablets contains Norfloxacin Tinidazole Excipients Approved colour used |
IP IP |
400mg 600mg qs |
| 216 | Rosuvastatin Tablets IP | Each film coated tablet contains Rosuvastatin Calcium eq. to Rosuvastatin |
IP | 5mg qs |
| 217 | Secnidazole Tablets IP | Each film coated tablets contains Secnidazole Excipients Approved colour used |
IP | 1000mg qs |
| 218 | Sertraline Tablets IP | Each film coated tablet contains Sertraline Hydrochloride Eq. to Sertraline Excipients Approved colour used |
IP | 50mg qs |
| 219 | Sertraline Tablets IP | Each film coated tablet contains Sertraline Hydrochloride Eq. to Sertraline Excipients Approved colour used |
IP | 100mg qs |
| 220 | Telmisartan Tablets IP | Each film coated tablet contains Telmisartan Excipients Approved colour used |
IP | 80 mg qs |
| 221 | Ursodeoxycholic Acid Tablets (S.R) | Each film coated sustained release tablet contains: Ursodeoxycholic Acid Excipients Approved colour used | IP | 500 mg qs |
| 222 | Voglibose Mouth Dissolving Tablets | Each mouth dissolving tablet contains Voglibose Excipients |
IP | 0.2 mg qs |
| 223 | Voglibose Mouth Dissolving Tablets | Each mouth dissolving tablet contains Voglibose Excipients |
IP | 0.3 mg qs |
| 224 | Ciprofloxacin Tablets IP | Each film coated tablets contains Ciprofloxacin HCl eq. to Ciprofloxacin Excipients |
IP | 250 mg qs |
| 225 | Montelukast Sodium Tablet IP | Each film coated tablet contains: Montelukast Sodium eq. to Montelukast Excipients |
IP | 5 mg qs |
| 226 | Aceclofenac Tablets IP | Each film coated tablet contains Aceclofenac Excipients Approved colour used |
IP | 100mg qs |
| 227 | Clopidogrel Bisulphate Tablets IP | Each film coated tablet contains Clopidogrel Bisulphate eq. to Clopidogrel Excipients Approved colour used |
IP | 75mg qs |
| 228 | Metformin HCl Tablets IP | Each film coated tablet contains Metformin HCl Excipients |
IP | 500mg qs |
| 229 | Teneligliptin 20mg & Metformin Hydrochloride 1000mg (SR) Tablets | Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Metformin Hydrochloride (Sustained Release) Excipients Approved colour used |
IP IP |
20mg 1000mg qs |
| 230 | Teneligliptin 20mg & Metformin Hydrochloride 500mg (SR) Tablets | Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Metformin Hydrochloride (Sustained Release) Excipients Approved colour used |
IP IP |
20mg 500mg qs |
| 231 | Ornidazole Tablets IP | Each film coated tablet contains: Ornidazole Excipients Approved colour used |
IP | 500mg qs |
| 232 | Labetalol Hydrochloride Tablets | Each film coated tablet contains: Labetalol Hydrochloride Eq. to Labetalol Excipients Approved colour used |
100mg qs | |
| 233 | Labetalol Hydrochloride Tablets | Each film coated tablet contains: Labetalol Hydrochloride Eq. to Labetalol Excipients |
IP | 200mg qs |
| 234 | Labetalol Hydrochloride Tablets | Each film coated tablet contains: Labetalol Hydrochloride Eq. to Labetalol Excipients Approved colour used |
IP | 400mg qs |
| 235 | Alpha Chemotrypsin Tablets | Each film coated tablet contains: Alpha Chemotrypsin Excipients |
IP | 100000I U qs |
| 236 | Eplerenone Tablets | Each film coated tablet contains: Eplerenone Excipients Approved colour used |
25mg qs | |
| 237 | Eplerenone Tablets | Each film coated tablet contains: Eplerenone Excipients Approved colour used |
50mg qs | |
| 238 | Linagliptin And Metformin Hydrochloride Tablets | Each film coated tablet contains Linagliptin Metformin Hydrochloride Excipients Approved color used | IP | 2.5mg 1000mg q.s. |
| 239 | Linagliptin And Metformin Hydrochloride Tablets | Each film coated tablet contains Linagliptin Metformin Hydrochloride Excipients Approved color used | IP | 2.5mg 850mg q.s. |
| 240 | Vildagliptin Tablets | Each uncoated tablet contains Vildagliptin Excipients Approved color used |
100mg qs | |
| 241 | Tolvaptan Tablets | Each film coated tablet contains Tolvaptan Excipients Approved color used |
15mg qs | |
| 242 | Prasugrel Hydrochloride Tablets | Each film coated tablet contains Prasugrel Hydrochloride Eq. to Prasugrel Excipients Approved color used |
5mg qs | |
| 243 | Prasugrel Hydrochloride Tablets | Each film coated tablet contains Prasugrel Hydrochloride Eq. to Prasugrel Excipients Approved color used |
10mg qs | |
| 244 | Ivabradine Hydrochloride Tablets | Each film coated tablet contains Ivabradine Hydrochloride Eq. to Ivabradine Excipients Approved color used |
5mg qs | |
| 245 | Ketoprofen and Thiocolchicoside Tablets | Each film coated tablet contains Ketoprofen Thiocolchicoside Excipients Approved color used |
IP | 50mg 4mg q.s. |
| 246 | Ketoprofen and Thiocolchicoside Tablets | Each film coated tablet contains Ketoprofen Thiocolchicoside Excipients Approved color used |
IP | 100mg 8mg q.s. |
| 247 | Labetalol Hydrochloride Tablets | Each film coated tablet contains Labetalol Hydrochloride Eq. to Labetalol Excipients Approved color used |
50mg qs | |
| 248 | Ranolazine extended Release Tablets | Each film coated extended release tablet contains Ranolazine Excipients |
375mg qs | |
| 249 | Ranolazine extended Release Tablets | Each film coated extended release tablet contains Ranolazine Excipients |
750mg qs | |
| 250 | Benidipine Hydrochloride Tablets | Each film coated tablet contains Benidipine Hydrochloride Excipients Approved color used |
4mg qs | |
| 251 | Benidipine Hydrochloride Tablets | Each film coated tablet contains Benidipine Hydrochloride Excipients Approved color used |
8mg qs | |
| 252 | Linagliptin Tablets | Each film coated tablet contains Linagliptin Excipients Approved color used |
5mg qs | |
| 253 | Linagliptin & Metformin Hydrochloride Tablets | Each film coated tablet contains Linagliptin Metformin Hydrochloride Excipients Approved color used | IP | 2.5mg 500mg q.s. |
| 254 | Ivabradine Hydrochloride Tablets | Each film coated tablet contains Ivabradine Hydrochloride Eq. to Ivabradine Excipients Approved color used |
7.5mg qs | |
| 255 | Fexofenadine Hydrochloride Tablets IP 180 mg | Each film coated tablet contains Fexofenadine Hydrochloride Excipients Approved colour used |
IP | 180 mg. qs |
| 256 | Terbinafine Hydrochloride Tablets I.P. | Each film coated tablet contains Terbinafine Hydrochloride Eq. to Terbinafine Excipients |
IP | 500 mg. qs |
| 257 | Ketoconazole Tablets I.P. | Each uncoated tablet contains Ketoconazole Excipients Approved colour used |
IP | 200 mg. qs |
| 258 | Montelukast Mouth Dissolving Tablets 4mg | Each uncoated mouth dissolving tablet contains: Montelukast Sodium Eq. to Montelukast Excipients |
IP | 4mg q.s. |
| 259 | Montelukast & Fexofenadine Hydrochloride Tablets | Each film coated tablet contains: Montelukast Sodium Eq. to Montelukast Fexofenadine Hydrochloride Excipients Approved Color Used |
IP IP |
10mg 120mg q.s. |
| 260 | Ketorolac Tromethamine Dispersible Tablets 10mg | Each Uncoated Dispersible tablet contains: Ketorolac Tromethamine Excipients Approved Color used |
IP | 10mg q.s. |
| 261 | Atorvastatin Tablets IP 40 mg | Each film coated tablet contains: Atorvastatin calcium Eq.to Atorvastatin Excipients Approved colour used |
IP | 40 mg qs |
| 262 | Ofloxacin Dispersable Tablets 100 mg | Each uncoated dispersible tablet contains: Ofloxacin Excipients Approved color used |
IP | 100 mg qs |
| 263 | Ondansetron Mouth Dissolving Tablets 4 mg | Each uncoated mouth dissolving tablet contains: Ondansetron Hydrochloride Eq to ondansetron Excipients Approved color used |
IP | 4mg q.s. |
| 264 | Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate & Caffeine Tablets | Each uncoated tablet contains: Paracetamol Phenylephrine Hydrochloride Chlorpheniramine Maleate Caffeine(anhydrous) Excipients Approved color used |
IP IP IP IP |
325 mg 5 mg 2 mg 16 mg qs |
| 265 | Thiamine Hydrochloride Tablets IP 100 mg | Each film coated tablets contains : Thiamine Hydrochloride Excipients Approved color used |
IP | 100 mg qs |
| 266 | Doxylamine, Pyridoxine &Folic acid Tablets | Each Enteric coated tablet contains: Doxylamine succinate Pyridoxine Hydrochloride Folic acid Excipients Approved color used |
USP IP IP |
10 mg 10 mg 2.5 mg qs. |
| 267 | Trypsin, Bromelain & Rutoside Trihydrate Tablets | Each enteric coated tablet contains : Trypsin Bromelain Rutoside Trihydrate Excipients Approved color used |
BP BP BP | 96 mg 180 mg 200 mg q.s. |
| 268 | Trypsin, Bromelain, Rutoside Trihydrate & Diclofenac Sodium Tablets | Each enteric coated tablet contains : Trypsin Bromelain Rutoside trihydrate Diclofenac sodium Excipients Approved color used |
BP BP BP IP | 48 mg 90 mg 100 mg 50 mg q.s. |
| 269 | Trypsin Chymotrypsin & Diclofenac Potassium Tablets | Each film coated tablet contains : 50000 Armour units of enzymatic activity) Supplied by a purified concentrate which has specific trypsin and chymotrypsin activity in a ratio of approx six to one Diclofenac Potassium (Enteric coated immediate Release ) Excipients Approved color used |
BP BP | 48 mg 50 mg qs |
| 270 | Trypsin,Bromelain & Rutoside Trihydrate Tablets | Each enteric coated tablet contains : Trypsin Bromelain Rutoside trihydrate Excipients Approved color used |
BP BP BP | 48 mg 90 mg 100 mg qs. |
| 271 | Tapentadol Tablets 100 mg | Each film coated tablet contains : Tapentadol Hydrochloride Eq to Tapentadol Excipients Approved color used |
IP | 100 mg qs |
| 272 | Tapentadol tablets 50 mg | Each film coated tablet contains : Tapentadol Hydrochloride Eq to Tapentadol Excipients Approved color used |
IP | 50 mg qs |
| 273 | Rosuvastatin Tablets IP 40 mg | Each film coated tablet contains : Rosuvastatin Calcium Eq to Rosuvastatin Excipients Approved color used |
IP | 40 mg qs. |
| 274 | Ondansetron Tablets IP 8 mg | Each uncoated tablet contains: Ondansetron Hydrochloride Eq to Ondansetron Excipients Approved color used |
IP | 8 mg qs |
| 275 | Nebivolol Tablets IP 5 mg | Each uncoated tablet contains : Nebivolol Hydrochloride Eq to Nebivolol Excipients Approved color used |
IP | 5 mg |
| 276 | Nebivolol Tablets IP 2.5 mg | Each uncoated tablet contains : Nebivolol Hydrochloride Eq to Nebivolol Excipients Approved color used |
IP | 2.5 mg |
| 277 | Montelukast & Doxofylline (sustained Release) tablets | Each uncoated bilayered tablet contains : Montelukast sodium Eq to Montelukast Doxofylline (Sustained Release ) Excipients Approved color used |
IP IP |
10 mg 400 mg q.s. |
| 278 | Levosulpiride Tablets 25 mg | Each uncoated tablet contains : Levosulpiride Excipients |
IP | 25 mg q.s |
| 279 | Levosulpride Tablets 50 mg | Each uncoated tablet contains : Levosulpride Excipients |
IP | 50 mg qs |
| 280 | Ketoconazole Tablets I.P.200 mg | Each uncoated tablet contains : Ketoconazole Excipients |
IP | 200 mg qs |
| 281 | Finasteride Tablets IP 1 mg | Each film coated tablet contains : Finasteride Excipients Approved color used |
IP | 1 mg qs |
| 282 | Escitalopram Tablets IP 20 mg | Each film coated tablet contains : Escitalopram Oxalate Eq to Escitalopram Excipients |
IP | 20mg qs |
| 283 | Betahistine Tablets 24 mg | Each uncoated tablet contains : Betahistine Hydrochoride Excipients | IP | 24 mg qs |
| 284 | Allopurinol tablets IP 300 mg | Each uncoated tablet contains : Allopurinol Excipients |
IP | 300 mg qs |
| 285 | Aceclofenac Tablets IP 100 mg | Each film coated tablet contains : Aceclofenac Excipients Approved color used |
IP | 100 mg qs |
| 286 | Aceclofenac, Paracetamol& Thiocolchicoside tablets | Each film coated tablet contains : Aceclofenac Paracetamol Thiocolchicoside Excipients Approved color used |
IP IP IP |
100 mg 325 mg 4 mg qs |
| 287 | Aceclofenac, Paracetamol & Thiocolchicoside Tablets | Each film coated tablet contains : Aceclofenac Paracetamol Thiocolchicoside Excipients Approved color used |
IP IP IP |
100 mg 325 mg 8 mg qs |
| 288 | Aceclofenac & Serratiopeptidase Tablets | Each film coated tablet contains : Aceclofenac Serratiopeptidase (As enteric coated granules eq to 30000 Serratiopeptidase units ) Excipients Approved color used |
IP IP |
100 mg 15 mg q.s. |
| 289 | Ondansetron Orally Disintegrating tablets IP 8 mg | Each uncoated Orally Disintegrating tablet contains: Ondansetron Hydrochloride eq to Ondansetron |
IP | 8 mg |
| 290 | Levofloxacin tablets IP 750 mg | Each film coated tablet contains : Levofloxacin Hemihydrate Eq to Levofloxacin Excipients Approved color used |
IP | 750 mg qs |
| 291 | Rabeprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: Rabeprazole Sodium Domperidone Excipients Approved Color Used |
IP IP |
20mg 10mg q.s. |
| 292 | Cholecalciferol Tablets IP | Each uncoated tablet contains: Cholecalciferol Excipients Approved color used in tablets |
IP | 60000 IU q.s. |
| 293 | Eperisone HCl Tablets | Each film coated tablet contains: Eperisone Hydrochloride Excipients Approved color used |
50mg | |
| 294 | Granisetron HCl Tablets IP | Each film coated tablet contains: Granisetron Hydrochloride Eq. to Granisetron Excipients |
IP | 1mg q.s. |
| 295 | Granisetron HCl Tablets IP | Each film coated tablet contains: Granisetron Hydrochloride Eq. to Granisetron Excipients |
IP | 2mg q.s. |
| 296 | Spironolactone & Frusemide Tablets | Each film coated tablets contains: Spironolactone Frusemide Excipients Approved color used |
IP IP |
50mg 20mg q.s. |
| 297 | Chlorpromazine HCl Tablets I.P. | Each film coated tablets contains: Chlorpromazine HCl Excipients Approved color used |
IP | 50mg q.s. |
| 298 | Chlorpromazine HCl Tablets I.P. | Each film coated tablets contains: Chlorpromazine HCl Excipients Approved color used |
IP | 100mg q.s. |
| 299 | Chlorpromazine HCl Tablets I.P. | Each film coated tablets contains: Chlorpromazine HCl Excipients Approved color used |
IP | 25mg q.s. |
| 300 | Piroxicam Sublingual Tablets IP 20 mg | Each uncoated Tablet Contains: Piroxicam Excipients Colour Approved Colour Used |
IP | 20 mg q.s |
| 301 | Esomeprazole Tablets I.P. 20mg | Each enteric coated tablets contains: Esomeprazole Magnesium Eq. to Esomeprazole Excipients |
IP | 20mg q.s |
| 302 | Nitrofurantoin SR Tabblet I.P. 100 mg | Each film coated (Sustained Release)Tablets contains: Nitrofurantoin Excipients Approved color used |
IP | 100 mg q.s |
| 303 | Acotiamide Hcl Tablets 100mg | Each film coated tablets contains Acotiamide Hydrochloride Excipients Approved color used |
IP | 100mg q.s |
| 304 | Invermectin & Albendazole Tablets | Each uncoated chewable tablets contains: Invermectin Albendazole Excipients Approved color used |
BP IP |
12mg 400mg q.s. |
| 305 | Deflazacort Tablet 30 mg | Each uncoated tablets contans: Deflazacort Excipients Approved color used |
IP | 30 mg q.s. |
| 306 | Aceclofenac and Drotaverine Hydrochloride Tablets | Each uncoated tablet contains: Aceclofenac Drotaverine Excipients Approved Colour Used |
IP IP |
100mg 80mg q.s. |
| 307 | Gabapentin & Methylcobalamin Tablets | Each film coated tablets contains: Gabapentin Methylcobalamin Excipients Approved Colour Used |
IP IP |
100 mg 500 mg q.s |
| 308 | Calcium & Cholecalciferol & Folic Acid Tablets | Each film coated tablets contains: Calcium (as Calcium Citrate Malate) Cholecalciferol (as Cholecalciferol Concentrate) Folic acid Excipients Approved Colour Used |
IP IP IP |
250 mg 100 IU 50 mcg q.s. |
| 309 | Leflunomide Tablets I.P. 20mg | Each film coated tablets contains: Leflunomjde Excipients Approved Colour Used |
IP | 20 mg q.s. |
| 310 | Leflunomide Tablets I.P. 10 mg | Each film Coated tablets contains: Leflunomide Excipients Approved Colour Used |
IP | 10 mg q.s. |
| 311 | Glimepride and Pioglitazone Tablets | Each Tablets Contains: Glimepride Piglitazone Hydrochloride eq. to Pioglitazone Excipients Approved Colour Used |
IP IP |
2 mg 15mg q.s |
| 312 | Cinnarizine Tablets IP 25 mg | Each film coated Tablets Contains Cinnarizine Excipients Approved Colour Used |
IP | 25 mg q.s. |
| 313 | Cinnarizine And Domperidone Tablets IP | Each Uncoated Tablets Contains Cinnarizine Domperidone Excipients Approved Colour Used |
IP IP |
20 mg 15 mg q.s. |
| 314 | Etizolam Tablets 0.25 mg | Each film coated tablets contains: Etizolam Excipients Approved Colour Used |
IP | 0.25 mg q.s. |
| 315 | Ethamsylate Tablets 250 mg | Each uncoated tablets contains: Ethamsylate Excipients Approved Colour Used |
IP | 250 mg q.s. |
| 316 | Ethamsylate & Tranex amic acid Tablets | Each film coated tablets contains: Ethamsylate Tranexamic Acid Excipients Approved Colour Used |
IP IP |
250 mg 250 mg q.s. |
| 317 | Fluconazole Tablets I.P. 400 mg | Each Uncoated Tablets Contains Fluconazole Excipients Approved Colour Used |
IP | 400 mg q.s |
| 318 | Methylecobalamine Pyridoxine Hcl & Folic Acid Tablets | Each film Coated tablets contans: Methylecobalamine (ER) Pyridoxine Hydrochloride (IR) Folic Acid (IR) Excipients Approved Colour Used |
IP IP IP |
1500 mcg 20mg 5gm q.s. |
| 319 | Ibuprofen And Paracetamol Tablets I.P. | Each Uncoated tablets contains: Ibuprofen Paracetamol Excipients Approved Colour Used |
IP IP |
400 mg 325 mg q.s. |
| 320 | Moxifloxacin Tablets 400 mg | Each film coated tablets contains: Moxifloxacin Hydrochloride eq to moxifloxacin Excipients Approved Colour Used |
IP | 400 mg q.s. |
| 321 | Fluconazole Tablets 200 mg | Each Un-coated tablets contains: Fluconazole Excipients Approved Colour Used |
IP | 200 mg q.s. |
| 322 | Telmisartan and Amlodlpine Tablets IP | Each uncoated tablet contains: Telmisartan Amlodipine Besylate Eq. to Amlodipine Excipients Approved Colour Used |
IP IP q.s. |
80 mg 5 mg q.s. |
| 323 | Olmesartan Medoximil Tablets IP 10mg | Each film-coated tablets contains: Olmesartan Medoximil Excipients Approved Colour Used |
IP | 10 mg q.s. |
| 324 | Olmesrtan Medoximil Tablets IP 20 mg | Each film-coated tablets contains: Olmesartan Medoximil Excipients Approved color used |
IP | 20 mg qs |
| 325 | Olmesartan Medoximil Tablets IP 40mg | Each film-coated tablets contains: Olmesartan Medoximil Hydrochlorthiazide Excipients Approved Colour Used |
IP IP q.s. |
40 mg 12.5 mg q.s. |
| 326 | Olmesartan Medoximil And Amlodipine Besilate Tablets | Each film-coated tablets contains: Olmesartan Medoximil Amlodipine Besylate Eq. to Amlodipine Excipients Approved Colour Used |
IP IP |
20 mg 5 mg q.s. |
| 327 | Olmesartan Medoximil And Hydrochlorthiazide IP Tablets | Each film-coated tablets contains: Olmesartan Medoximil Hydrochlorthiazide Excipients Approved Colour used |
IP IP |
20 mg 12.5 mg q.s. |
| 328 | Olmesartan Medoximil And Amlodipine Besilate Tablets | Each film-coated tablets contains: Olmesartan Medoximil Amlodipine Besylate Eq. to Amlodipine Excipients Approved Colour Used |
IP IP |
40 mg 5 mg q.s. |
| 329 | Paracetamol Sustained Release Tablets 1000 mg | Each uncoated bilayered tablet contains: Paracetamol (As immediate release) Paracetamol (As sustained release) Excipients Approved Colour Used |
IP IP |
300 mg 700 mg q.s. |
| 330 | Glimepiride, Pioglitazone Hydrochloride And Merformin Hydrochloride (ER) Tablets | Each uncoated bilayered tablet contains: Glimepiride Pioglitazone Hydrochloride Eq. to pioglitazone Metformin Hydrochloride (As Extended Release) Excipients |
IP IP IP |
1mg 15 mg 500 mg q.s. |
| 331 | Glimepiride, Pioglitazone Hydrochloride And Metformin Hydrochloride (ER) Tablets | Each uncoated bilayered tablet contains: Glimepride Pioglitazone Hydrochloride Eq. to Pioglitazone Metformin Hydrochloride (As Exended Release) Excipients |
IP IP IP |
2mg 15mg 500mg q.s. |
| 332 | Metformin Hydrochloride Sustained Release Tablet I.P. | Each uncoated tablet contains: Metformin Hydrochloride Excipients Approved Colour Used |
IP | 1000 mg Qs. |
| 333 | Telmisartan, Amlodipine Besilate & Hydrochlort hiazide Tablets | Each uncoated tablet contains: Telmisartan Hydrochlorthiazide Amlodipine Besilate Eq. to Amlodipine Excipients Approved Colour Used |
IP IP IP |
40mg 12.5mg 5mg q.s. |
| 334 | Nitroglycerin SR Tablets 2.6 mg | Each uncoated Sustains release tablet Diluted Nitroglycerin Eq. to Nitroglycerin Excipients Approved Colour used |
IP | 2.6 mg qs |
| 335 | Ivermectin Tablets 6 mg | Each film coated tablets contans: Ivermectin Excipients Approved Colour Used |
IP | 6 mg q.s |
| 336 | Drotaverine Hydrochloride Tablets IP 80 mg | Each Uncoated Tablets Contains Drotaverine Hydrochloride Excipients Approved Colour Used |
IP | 80 mg q.s. |
| 337 | Allopurinol Tablets I.P. 100 mg | Each Uncoated tablets Contains: Allopurinol Excipients Approved Colour Used |
IP | 100 mg q.s. |
| 338 | Alendronate Sodium Tablets USP 70 mg | Each Uncoated tablets contains: Alendronate Sodium trihydrate 91.37 mg eq. to as alendronic acid 70 mg. Excipients |
USP | 70 mg q.s. |
| 339 | Naproxen and Domperidone Tablets | Each Film coated tablets contains: Naproxen Sodium e.q. to Nopoxen Domperidone Excipients Approved Colour Used |
USP IP | 500 mg 10 mg q.s. |
| 340 | Itraconazole Dusting Powder 1.0% w/w | Each Dusting Powder Contains: Itraconazole Excipients Approved Colour Used |
IP | 1.0% w/w q.s. |
| 341 | Terbinafine Hcl Dusting Powder 1.0 % w/w | Each Dusting Powder Contains: Terbinafine Hydrochloride eq. to Terbinafine Powder Base Approved Colour Used |
IP | 1.0% w/w q.s |
| 342 | Tolperisone & Paracetamol Tablets | Each film coated tablets contains Tolperisone Hydrochloride Paracetamol Excipients |
IP IP |
150 mg 500 mg q.s. |
| 343 | Ketoconazole Dustin Powder 2.0 % w/w | Composition: Ketoconazole Excipients Talc Perfumed Base | IP IP |
2.0% w/w q.s. |
| 344 | Telmisartan & Amlodipine Tablets I.P. | Each Uncoated bilayerd tablets contains: Telmisartan Amlodipine Besilate Eq. to Amlodipine Excipients Approved Colour Used |
IP IP |
40 mg 5 mg |
| 345 | Pioglitazone Tablets I.P. 15 mg | Each Uncoated tablets Contains: Pioglitazone Eq. to Pioglitazone Excipients Approved Colour Used |
IP | 15 mg q.s. |
| 346 | Sodium Chloride Nasal 0.065% w/v | Composition: Sodium Chloride Porified Water PreservativeBenzalkonum Chloride Ap proved Colour Used |
IP IP IP |
0.065 % w/w q.s. 0.01%w /v |
| 347 | Diclofenac Diethylamine, Methyl Salicylate, Peppermine Oil, Eucalyptus Oil, Turpentine Oil |
Composition: Diclofenac Diethylamine Methyl Salicylate Peppermint Oil Eucalyptus Oil Turpentine Oil In Oil Base Approved Colour Used |
IP IP IP IP BP |
2% w/w 10% w/w 10% w/w 5% w/w/w 10% |
| 348 | Amisulpride Tablets I.P 200mg | Each Uncoated tablet Contains: Ammisulpride Excipients Approvied Colour Used |
IP | 200mg q.s. |
| 349 | Cilindipine Tablets I.P 10 mg | Each Film Coated Tablets Contains: Cilindipine Excipients Approved Colour Used |
IP | 10 mg q.s. |
| 350 | Amisulpride Tablets I.P 100 mg | Each Uncoated Tablet Contains: Amisulpride Excipients Approved Colour Used |
IP | 100 mg q.s. |
| 351 | Nimesulide Mouth Dissolving Tablets 100mg | Each Mouth Dissolving Tablets Contains: Nimesulide Excipients Approved Colour |
BP | 100mg q.s. |
| 352 | Diclofenac Sodium SR Tablets | Each film coated sustained release tablet contains: Diclofenac Sodium Excipients Approved color used |
IP | 100mg q.s. |
| 353 | Diclofenac Sodium SR Tablets | Each film coated sustained release tablet contains: Diclofenac Sodium Excipients Approved color used |
IP | 75mg q.s. |
| 354 | Paracetamol & Domperidone Tablets | Each film coaated tablet contains: Paracetamol Domperidone Maleate Eq. to Domperidone Excipients Approved color used |
IP IP |
325mg 10mg q.s. |
| 355 | Lornoxicam Extended Release Tablets | Each film-coated extended release tablet contains: Lornoxicam Excipients Approved color used |
IP | 16mg q.s. |
| 356 | Torsemide & Spironolactone Tablets | Each uncoated tablet contains: Torsemide Spironolactone Excipients Approved color used |
IP IP |
10mg 50mg q.s. |
| 357 | Torsemide & Spironolactone Tablets | Each uncoated tablet contains: Torsemide Spironolactone Excipients Approved color used |
IP IP |
20mg 50mg q.s. |
| 358 | Rabeprazole Sodium Tablets IP 10mg | Each enteric coated tablet contains: Rabeprazole Sodium Excipients Approved color used |
IP | 10mg q.s. |
| 359 | Pantoprazole (EC) & Domperidone Tablets | Each uncoated tablet contains: Pantoprazole Sodium Eq. to Pantoprazole Domperidone (In Immediate release form) Excipients Approved color used |
IP IP |
20mg 10 q.s. |
| 360 | Tadalafil Tablets IP | Each film coated tablet contains: Tadalafil Excipients Approved color used |
IP | 5mg q.s. |
| 361 | Tadalafil Tablets IP | Each film coated tablets contains: Tadalafil Excipients Approved color used |
IP | 10mg q.s. |
| 362 | Tadalafil Tablets IP | Each film coated tablet contains: Tadalafil Excipients Approved color used |
IP | 20mg q.s. |
| 363 | Finasteride & Biotin Tablets | Each Film Coated tablet Finasteride Biotin Excipients Approved color used |
IP BP | 1mg 10mg q.s. |
| 364 | Finasteride Tablets IP 5 mg | Each film coated tablet contains: Finasteride Excipients Approved color used |
IP | 5mg q.s. |
| 365 | Lamotrigine Dispersible Tablets IP | Each film coated tablet contains: Lamotrigine Excipients Approved color used |
IP | 50mg q.s. |
| 366 | Lamotrigine Dispersible Tablets IP | Each dispersible uncoated tablet contains: Lamotrigine Excipients Approved color used |
IP | 100mg q.s. |
| 367 | Glucosamine Tablets USP | Each film coated tablets contains: Glucosamine Sulphate Potassium Chloride Eq. to Glucosamine Excipients |
UPS | 1000mg 691.79 mg q.s. |
| 368 | Sumatriptan Tablets | Each film coated tablet contains: Sumatriptan Succinate Eq. to Sumatriptan Excipients Approved color used |
IP | 25mg q.s. |
| 369 | Sumatriptan Tablets | Each film coated tablet contains: Sumatriptan Succinate Eq. to Sumatriptan Excipients Approved color used |
IP | 50mg q.s. |
| 370 | Sumatriptan Tablets | Each film coated tablet contains: Sumatriptan Succinate Eq. to Sumatriptan Excipients Approved color used |
IP | 100mg q.s. |
| 371 | Susralfate Tablets IP | Each film coated tablet contains: Sucralfate Excipients Approved color used |
IP | 1gm q.s. |
| 372 | Amiodarone Tablets IP | Each film coated tablet contains: Amiodarone Hydrochloride Excipients Approved color used |
IP | 200mg q.s. |
| 373 | Levocarnitine Tablets IP | Each film coated tablet contains: Levocarnitne Excipients Approved color used |
IP | 500mg q.s. |
| 374 | Alfacalcidol, Calcium & Zinc Tablets | Each film coated tablets contains: Alfacalcidol Calcium Carbonate Eq. to elemental Calcium Zinc Sulphate Monohydrate Eq. to elemental Calcium Excipients Approved color used |
IP IP IP |
0.25mc g 500mg 200mg 7.5mg q.s. |
| 375 | Tolvaptan Tablets | Each film coated tablet contains: Tolvaptan Excipients Approved color used |
IP | 30mg q.s. |
| 376 | Glibenclamide & Metformin Tablets IP | Each film coated tablet contains: Glibenclamide Metformin Hydrochloride Excipients Approved color used |
IP IP | 2.5mg 500mg q.s. |
| 377 | Glibenclamide & Metformin Tablets IP | Each film coated tablets contains: Glibenclamide Metformin Hydrochloride Excipients Approved color used |
IP IP |
5mg 500mg q.s. |
| 378 | Norfloxacin Tablets IP | Each film coated tablet contains: Norfloxacin Excipients Approved color used |
IP | 400mg q.s. |
| 379 | Ferrous Fumarate & Folic Acid Tablets IP | Each film coated tablet contains: Ferrous Fuamarate Folic Acid Excipients Approved color |
IP IP |
150mg 1.5mg q.s. |
| 380 | Betamethasone Tablets IP | Each uncoated Tablet Contains: Betamethasone Sodium Phosphate Eq. to Betamethasone Excipients Approved color used |
IP | 0.5mg q.s. |
| 381 | Betamethasone Tablets IP | Each uncoated tablets contain: Betamethasone Sodium Phosphate Eq. Betamethasone Excipients Approved color used |
IP | 1mg q.s. |
| 382 | Nifedipine Extended-release Tablets IP | Each extended-release tablet contains: Nifedipine Excipients Approved color used |
IP | 10mg q.s. |
| 383 | Topiramate Tablets IP | Each film coated tablet contains: Topiramate Excipients Approved Color used |
IP | 25mg q.s. |
| 384 | Nebivolol & Hydrochlorothiazide Tablets | Each film coated tablet contains: Nebivolol Hydrochloride Eq. to Nehivolol Hydrochlorothiazide Excipients Approved color used |
IP IP |
5mg 12.5mg q.s. |
| 385 | Etodolac & Thiocolchicoside Tablets | Each film coated tablet contains: Etodolac Thiocolchicoside Excipients Approved color used |
IP IP |
300mg 8mg q.s. |
| 386 | Lornoxicam & Thiocolchicoside Tablets | Each Film coated contains: Lornoxicam Thiocolchicoside Excipients Approved color used |
IP | 8mg 4mg q.s. |
| 387 | Doxofylline & Ambroxol Tablets | Each film coated tablet contains: Doxofylline Ambroxol Hydrochloride Excipients Approved Color used |
IP IP |
400mg 30mg q.s. |
| 388 | Nimesulide, Paracetamol, Phenylephrine HCL, Caffeine Tablets | Each uncoated Tablet Contains: Nimesulide Paracetamol Phenylephrine HCL Caffeine (Anhydrous) Excipients Approved Color used |
IP IP IP IP |
100mg 325mg 10mg 25mg q.s. |
| 389 | Telmisartan & Hydrochlorothiazide Tablets IP | Each film coated tablet contains: Telmisartan Hydrochlorothiazide Excipients Approved color used |
IP IP |
80mg 12.5 q.s. |
| 390 | Levocetirizine Hydrochloride, Phenylephrine Hydrochloride & Paracetamol Tablets | Each film coated tablet contains Levocetirizine Hydrochloride Phenylephrine Hydrochloride Paracetamol Excipients Approved color used |
IP IP |
5mg 500mg q.s. |
| 391 | Olmesartan Medoxomil & Metoprolol Succinate (Extended Release) Tablets | Each film coated tablets contains: Olmesartan Medoxomil Metoprolol Succinate eq. to Metoprolol Tartrate Excipients Approved color used |
IP IP |
20mg 47.5mg 50mg q.s. |
| 392 | Olmesartan Medoxomil & Metoprolol Succinate (Extended Release) Tablets | Each film coated tablets contains: Olmesartan Medoxomil Metoprolol Succinate eq. to Metoprolol Tartrate Excipients Approved color used |
IP IP |
20mg 23.75m g 25mg q.s. |
| 393 | Cilindipine Tablets 5mg | Each film coated tablet contains: Cilnidipine Excipients Approved color use |
IP | 5mg q.s. |
| 394 | Olmesartan Medoxomil, Amlodipine & Hydrochlorothiazide Tablets | Each film coated tablet contains: Olmesartan Medoxomil Amlodipine Besilate eq. to Amlodipine Hydrochlorothiazide Excipients Approved color used |
IP IP IP |
20mg 5mg 12.5mg q.s. |
| 395 | Olmesartan Medoxomil, Amlodipine & Hydrochlorothiazide Tablets | Each film coated tablet contains: Olmesartan Medoxomil Amlodipine Besilate eq. to Amlodipine Hydrochlorothiazide Excipients Approved color used |
IP IP IP |
40mg 5mg 12.5 mg q.s. |
| 396 | Sodium Feredetate, Folic Acid And Vitamin B12 Tablets | Each film coated tablet contains: Sodium Feredetate (Eq. to 33mg Elemental Iron) Folic acid Vitamin B12 Excipients Approved color Used |
BP IP IP |
231mg 1.5mg 15mcg q.s. |
| 397 | Telmisartan & Chlorthalidone Tablets | Each uncoated bilayered tablet contains: Telmisartan IP Chlorthalidone IP Excipients Approved color used |
IP IP |
40mg 12.5mg q.s. |
| 398 | Calcium Orotate And Vitamin D3 Tablets | Each film-coated tablets contains: Calcium Orotate Dhihydrate Eq. to Calcium Orotate Cholecalciferol (Vitamin D3) Excipients Approved color used |
IP IP |
740mg 1000 IU q.s. |
| 399 | Acebrophyline Sustained Release 200mg Tablets | Each film-coated sustained release tablet contains: Acebrophylline Excipients Approved color used |
IP | 200 mg q.s. |
| 400 | Cilnidipine And Metoprolol Succinate ER Bilayered Tablets | Each film coated bilayered tablet contains: Cilnidipine Metoprolol Succinate IP Eq. to Metoprolol Tartarate (in extended releae form) Excipients Approved color used |
IP IP |
10mg 23.75 25mg q.s. |
| 401 | Cilnidipine And Metoprolol Succinate ER Bilayered Tablets | Each film coated bilyaered tablet contains: Cilnidipine Metoprolol Succinate Eq. to Metoprolol Tartarate (In extended release form) Excipients Approved color used |
IP IP |
10mg 47.5 50mg q.s. |
| 402 | Telmisartan & Chlorthalidone Tablets | Each uncoated bilayered tablet contains: Telmisartan IP Chlorthalidone IP Excipients Approved color used |
IP IP |
80mg 12.5mg q.s. |
| 403 | Tadalafil Tablets IP | Each film coated tablet contains: Tadalafil IP Excipients Approved color used |
IP | 20mg q.s. |
| 404 | Tolperisone Hydrochloride & Diclofenac Sodium Tablets | Each film coated tablet contain: Tolperisone Hydrochloride Diclofenac Sodium Excipients Approved color used |
IP IP |
150mg 50mg |
| 405 | Etizolam Tablets IP 0.5 mg | Each uncoated tablet contains: Etizolam IP E xcipients Approved color used |
IP | 0.5 mg q.s. |
| 406 | Adenosylcobalam in, Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablets | Each film coated contains: Adenosylcobalamin Ferrous Ascorbate Zinc Sulphate Eq. to elemental zinc Folic Acid Excipients Approved color used |
IP IP USP IP |
15mg 100mg 22.5mg 1.5mg q.s. |
| 407 | Amlodipine Besilate & Metoprolol Succinate Tablets | Each film coated bilayered tablet contains: Amlodipine Besilate IP Eq. to Amlodipine Metoprolol Tartrate Eq. to Metoprolol Tartrate (As extended release form) Excipients |
IP IP |
5mg 47.5mg 50mg q.s. |
| 408 | Amlodipine Besilate & Metoprolol Succinate Tablets | Each film coated bilyered tablet contaisn: Amlodipine Besilate Eq. to Amlodipine Metoprolol Succinate Eq. to Metoprolol Tartrate (As extended release form) Excipients Approved Color used |
IP IP |
5mg 23.75m g 25mg q.s. |
| 409 | S-Amlodipine Besilate Tablets IP | Each uncoate tablet contains S-Amlodipine Besilate Eq. to Amlodipine Excipients Approved Color used |
IP | 2.5 mg q.s. |
| 410 | Calcium Carbonate & Alfacalcidol Tablets | Each film coated tablet contains: (Form an organic source oyster shells) Eq. to elemental calcium Alfacalcidol Excipients Approved color used |
BP | 1250mg 500mg 0.25mc g q.s. |
| 411 | Biotin, Calcium Pantothenate, Acetylcysteine & Minerals Tablets | Each fiml coated tablet contains: Biotin Sodium Selenate Eq. to Elmental Selenium N-Acetyl-cysteine Cupric Oxide Eq. to Elemental Copper Zinc Oxide Eq. to Elemental Zinc Calcium Pantothenate Excipients Approved Color used |
UPS UPS UPS IP IP IP |
10mg 65mg 50mg 3mg 22.5mg 100 mg q.s. |
| 412 | Telmisartan & Metoprolol Succinate (ER) Tablet | Each film bilayer coated tablet contains: Telmisartan IP Metoprolol Succinate Eq. to Metoprolol Tartrate Excipients Approved Color used |
IP | 40mg 47.5mg 50mg q.s. |
| 413 | Chlorthalidone Tablets | Each uncoated tablet contains: Chlorthalidone Excippients Approved color used |
IP | 6.25mg q.s. |
| 414 | Sitagliptin Tablet IP | Each film coated tablet contains: Sitagliptin Excipients Approved color used |
IP | 50mg q.s. |
| 415 | Sitagliptin Tablet IP | Each film coated tablet contains: Sitagliptin Excipients Approved color used |
IP | 100mg |
| 416 | Metformin Hydrochloride (SR) & Glimepride Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride (as Sustained release form) Glimepiride Excipients Approved color used |
IP IP |
1000mg 4.0mg q.s. |
| 417 | Dapagliflozine 10mg Tablets | Each film coaated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin Excipients Approved color used |
IP | 10mg q.s. |
| 418 | Dapagliflozine 5mg Tablets | Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin Excipients Approved color used |
IP | 5mg |
| 419 | Ticagrelor 90mg Tablets | Each film coated tablet contains: Ticagrelor Excipients Approved color used |
IP | 90mg q.s. |
| 420 | Naproxen Tablets I.P. 250 mg | Each uncoated Tablet Contains: Naproxen Excipients Colour Approved Colour Used |
IP | 250 mg q.s. |
| 421 | Bisoprolol 5mg Tablets | Each film coated tablet contains: Bisoprolol Fumarate Excipients Approved Color used |
IP | 5 mg q.s. |
| 422 | Bisoprolol 10mg Tablets | Each film coated tabletcontains: Bisoprolol Fumarate Excipients Approved color used |
UPS | 10mg q.s. |
| 423 | Ursodeoxycholic Acid SR 450mg Tablets | Each fiml coated sustained release tablet contains: tablet contains: Ursodexycholic Acid Excipients Approved color used |
IP | 450mg q.s. |
| 424 | Isoxsuprine Hydrochloride Sustained Release Tablets | Each film coated sustained release tablet contains: Isoxsuprine Hydrochloride Excipients Approved color used |
IP | 40mg q.s. |
| 425 | Tolperisone Hydrochloride & Diclofenac Sodium Tablets | Each film coated tablet contains: Tolperisone Hydrochloride Diclofenac Sodium Excipients Approved color used |
IP IP |
150mg 50mg q.s. |
| 426 | Sodium Valproate & Valproic Acid Controlled Release Tablets | Each film coated controled release tablet contains: Sodium Valproate Valproic Acid (Both together corresponds to Sodium Valproate 300mg) Excipients Approved color used |
IP IP |
200mg 87mg |
| 427 | Amitriptyline Hydrochloride Tablet IP | Each film coated tablet contains: Amitriptyline Hydrochloride Excipients Approved color used |
IP | 10mg q.s. |
| 428 | Amitriptyline Hydrochloride Tablet IP | Each film coaated tablet contains: Amitriptyline Hydrochloride Excipients Approved color used |
IP | 25mg q.s |
| 429 | Amitriptyline Hydrochloride Tablet IP | Each film coated tablet contains: Amitriptyline Hydrochloride Excipients Approved color used |
IP | 50mg q.s. |
| 430 | Griseofulvin 500mg Tablets | Each uncoated tablet contains: Griseofulvin Excipients Approved color used |
IP | 500mg q.s. |
| 431 | Nortriptyline Tablets IP | Each film coated tablet contains: Nortriptyline Hydrochloride Eq. to Nortriptyline Excipients Approved color used |
IP | 10mg q.s. |
| 432 | Nortriptyline Tablets IP | Each film coated tablet contains: Nortriptyline Hydrochloride Eq. to Nortriptyline Excipients Approved color used |
IP | 25mg q.s |
| 433 | Lisinopril Tablet IP | Each uncoated tablet contains: Lisinopril IP Excipients Approved color used |
IP | 10mg q.s. |
| 434 | Cabergoline Tablets IP | Each uncoated tablet contains: Cabergoline Excipients Approved color used |
IP | 0.5mg q.s. |
| 435 | Primaquine Tablets IP | Each film coated tablets contains: Primaquine Phosphate Eq. to Primaquine Excipients Approved color used |
IP | 7.5mg q.s. |
| 436 | Primaquine Tablets IP | Each film coated tablets contains: Primaquine Phosphate Eq. to Primaquine Excipients Approved color used |
IP | 15 mg q.s. |
| 437 | Bisoprolol 5mg & Telmisartan 40 mg Tablets | Each film locted tablet contains: Flupirtine Maleate Excipients Approved color used |
UPS IP | 5mg 40mg q.s. |
| 438 | Flupirtine Masteate 100mg Tablets | Each film coated tablets contains: Flupirtine Maleate Excipients Approved color used |
USP | 100mg q.s. |
| 439 | Flupirtine Masteate 100mg & Paracetamol 325mg Tablets | Each film coated tablets contains: Flupirtine Maleate Paracetamol Excipients Approved color used |
USP IP | 100mg 325mg q.s. |
| 440 | Amorolfine Hydrochloride 0.25% w/w & Phenoxyethanol 1.00% w/w Cream | Each film coated tablet contains: Amorolfine Hydrochloride Phenoxyethanol Excipients Approved color used |
0.25%w /w 1.0%w/ w q.s. |
|
| 441 | Silodosin 8mg & Dutastried 0.5mg Tablets | Each hard gelatin capsules contains: Silodosin Dutastried Excipients Approved color used |
8.0mg 0.5mg q.s. | |
| 442 | Pregabalin + Methylcobalamin & Nortriptyline Tablets | Each film coated Tablet Contains Pregabalin Methylcobalamin Nortriptyline Hydrochloride eq. To Nortriptyline Excipients Approved color used |
IP IP IP |
75mg 1500mc g 10mg q.s. |
| 443 | Aceclofenac, Paracetamol And Serratiopeptidase Tablets | Each film coated tablets contaisn: Aceclofenac Paracetamol Serratiopeptidase Excipients Approved color used |
IP IP IP |
100mg 325mg 15mg q.s. |
| 444 | Aceclofenac, Paracetamol And Serratiopeptidase Tablets | Each film coated tablets contaisn: Aceclofenac Paracetamol Serratiopeptidase Excipients Approved color used |
IP IP IP |
100mg 325mg 10mg q.s. |
| 445 | Diclofanac, Paracetamol And Serratiopeptidase Tablet | Each film coated tablets contains: Diclofanac Paracetamol Serratiopeptidase Excipients Approved color used |
IP IP IP |
50mg 325mg 15mg q.s. |
| 446 | Diclofanac, Paracetamol And Serratiopeptidase Tablet | Each film coated tablets contains: Diclofanac Paracetamol Serratiopeptidase Excipients Approved color used |
IP IP IP |
50mg 325mg 10mg q.s. |
| 447 | Iveermectin Tablets | Each un coated tablet contains: Ivermectin Excipients Approved color used |
IP | 12mg q.s. |
| 448 | Naproxen Sodium And Domperidone Tablets | Each film coated tablet contains: Naproxen Sodium Domperidone Maleate Eq. to domperidone Excipients Approved color used |
IP IP |
250mg 10mg q.s. |
| 449 | Rosuvastatin, Aspirin And Clopidogrel Tablets | Each film coated tablet contains: Rosuvastatin Calcium Eq. to Rosuvastatin Aspirin Clopidogrel Bisulphate Eq. to Clopidogrel Excipients Approved color used |
IP IP IP |
10mg 75mg 75mg q.s. |
| 450 | Aceclofenac, Paracetamol And Trypsin Chymotrypsin Tablets | Each enteric coated tablet contains: 50000 Armour units of enzymatic activity supplied by a purified concentrate which has specific Trypsin and Chymotrypsin activity in the ratio of approximately six to one aceclofenac Aceclofenac Paracetamol Excipients Approved color used |
IP IP |
100mg 325mg q.s |
| 451 | Prochlorperazine Maleate Mouth Dissolving Tablet | Each uncaoted mouth dissolving tablet contains: Prochlorperazine Excipients Approved color used |
IP | 5mg q.s. |
| 452 | Sitagliptin 100mg & Metformin 1000mg | Each film coated tablet contains: Sitagliptin Metformin Hydrochloride Excipients Approved color used |
IP IP |
100mg 1000mg q.s. |
| 453 | Myo-Inosiol And Metformin Hydrochloride Tablets | Each film-coated tablets contains: Myo-Inositol Excipients Metformin Hydrochloride Excipients Approved color used |
USP IP | 750mg 500mg q.s |
| 454 | Myo-Inosiol And Metformin Hydrochloride Tablets | Each film-coated tablets contains: Myo-Inositol Excipients Metformin Hydrochloride (As Sustained Release) Excipients Approved color used |
USP IP | 600mg 500mg q.s. |
| 455 | Gabapentin And Nortryptyline Hydrochlorride Tablets | Each film coated talet contains: Gabapentin Nortryptyline Hydrochloride Eq. to Nortryptyline Excipients Approved color used |
IP IP |
400mg 10mg q.s. |
| 456 | Azithromycin And Lactic Acid Bacillus Tablets | Each film coated tablet contains: Azithromycin Dihydrate Eq. to Azithromycin Lactic Acid Bacillus Excipients Approved color used |
IP IP |
250mg 60 million q.s. |
| 457 | Azithromycin And Lactic Acid Bacillus Tablets | Each film coated tablet contains: Azithromycin Dihydrate Eq. to Azithromycin Lactic Acid Bacillus Excipients Approved color used |
IP IP |
500mg 60 million q.s. |
| 458 | Eperisone Hydrochloride Tablets 150mg | Each film coated tablet contain: Eperisone Hydrochloride Excipients Approved color used |
IP | 150mg q.s. |
| 459 | Torsemide Tablets USP 40mg | Each uncoaated tablet contains: Torsemide Excipients Approved color used |
USP | 6.4mg q.s. |
| 460 | Torsemide Tablets USP 100mg | Each uncoated tablet contains: Torsemide Excipients Approved color used |
USP | 100mg q.s. |
| 461 | Controlled Release Tablets of Nitroglycerin 6.4mg | Each uncoated controlled release tablet contains: Diluted Nitroglycerin Eq. to Nitroglycerin Excipients Approved color used |
USP | 6.4mg q.s. |
| 462 | Domperidone & Paracetamol Tablets | Each uncoated tablet contains: Domperidone Paracetamol Excipients Approved color used |
IP IP |
10mg 325mg q.s. |
| 463 | Calcium, Magnesium, Zinc & Vitamin D3 Lysine, Boron, Selenium & Copper Tablets | Each film coated tablet contains: Calcium Carbonate IP Eq. to Elemental Calcium Magnesium Hydroxide Eq. to Elemental Magneisum Zinc Sulphate Monohydrate Eq. to Elemental Zinc Vitamin D3 (As Stabilized) Lysine Hydrochloride Sodium Borate Eq. to Boron Sodium Selenate Eq. to Elemental Selenium Copper Sulphate Eq. to Elemental Copper Excipients Approved color used |
IP IP IP USP BP USP |
500mg 75mg 4mg 200 IU 1mg 35mcg 1mcg q.s. |
| 464 | Co-Enzyme Q10, L-Caarnitine, Lycopene & Zinc Tablets | Each film coated tablet contains: Co-Enzyme Q10 (Ubidecarenone) L-Carnitine Lycopene 10% Zinc Sulphate Monhydrate Eq. to Elemental Zinc Excipients Approved color used |
BP USP USP IP |
50mg 500mg 2500mg 12.5mg q.s. |
| 465 | Metformin Hydrochloride(Sustained Release), Glimepiride & Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride (as Sustained release form) Glimepiride Voglibose Excipients Approved color used |
IP IP IP |
500mg 1mg 0.2mg q.s. |
| 466 | Metformin Hydrochloride(Sustained Release), Glimepiride & Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride (as Sustained release form) Glimepiride Voglibose Excipients Approved color used |
IP IP IP |
500mg 1mg 0.3mg q.s. |
| 467 | Metformin Hydrochloride(Sustained Release), Glimepiride & Voglibose Tablets | Each uncoaated bilayered tablet contains: Metformin Hydrochloride (As sustained release form) Glimepiride Voglibose Excipients Approved color used |
IP IP IP |
500mg 2mg 0.2mg q.s. |
| 468 | Metformin Hydrochloride(Sustained Release), Glimepiride & Voglibose Tablets | Each uncoaated bilayered tablet contains: Metformin Hydrochloride (As sustained release form) Glimepiride Voglibose Excipients Approved color used |
IP IP IP |
500mg 2mg 0.3mg q.s. |
| 469 | Pregabalin And Nortriptyline Tablets | Each film coated tablet contains: Pregabalin Nortriptyline Hydrochloride Eq. to Nortriptyline Excipients Approved color used |
IP IP |
75mg 10mg q.s. |
| 470 | Levofloxacin & Ornidazole Tablets | Each film coaated tablet contains: Levofloxacin Hemihydrate Eq. to Levofloxacin Ornidazole Excipients Approved color used |
IP IP |
250mg 500mg q.s. |
| 471 | Acebrophylline(SR), Fexofenadine & Montelukast Sodium Tablets | Each film coated tablet contains: Acebrophylline (as sustained release form) Fexofenadine Hydrochloride Montelukast Sodium Eq. to Montelukast Excipients Approved color used |
IP IP |
200mg 120mg 10mg q.s. |
| 472 | L-Methylfolate, Methylcobalamin & Pyridoxal-5-Phosphate Tablets | Each film coated tablet contains: L-Methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Approved color used |
IP | 1mg 1500mcg 0.5mg q.s. |
| 473 | Montelukast, Levocetirizine Hydrochloride & Ambroxol Hydrochloride(SR) Tablets | Each film coated bilayered tablet contains: Montelukast Sodium Eq. to Montelukast Levocetirizine Hydrochloride Ambroxol Hydrochloride (In sustained release form) Excipients Approved color used |
IP IP IP |
10mg 5mg 75mg q.s. |
| 474 | Ginkgo Biloba Dry Extract Tablets USP | Each film coated tablet contains: Dried Extract of Ginkgo Biloba (contains 9.6mg of Ginkgo Flavone glycoside) Excipients Approved color used |
IP | 40mg q.s. |
| 475 | Ofloxacin & Flavoxate Hydrochloride Tablets | Each film coated tablet contains: Ofloxacin Flavoxate Hydrochloride Excipients Approved color used |
IP IP |
200mg 200mg q.s. |
| 476 | Tryspin, Bromelain, Rustoside Trihydrate & Aceclofenac tablets | Each enteric coated tablet contains: Trypsin Bromelain Rutoside Trihydrate Aceclofenac Excipients Approved color used |
IP BP IP |
48mg 90mg 100mg 100mg q.s. |
| 477 | Prulifloxacin Tablets 600mg | Each film coated tablet contains: Purifloxacin Excipients Approved color used |
IP | 600mg q.s. |
| 478 | L-Ornithine L-Aspartate & Pancreatin Tablets | Each enteric coated tablet contains: L-Ornithine L-Aspartate Pancreatin Excipients Approved Color used |
IP | 150mg 100mg q.s |
| 479 | Pantoprazole & Ondansetron Tablets | Each film coated tablet contains: Pantoprazole Sodium Eq. to Pantoprazole Ondansetron Hydrochloride Eq. to Ondansetron Excipients Approved color used |
IP IP |
40mg 4mg q.s. |
| 480 | Diclofenac Potassium, Paracetamol & Chlorzoxazone | Each film coated tablet contains: Diclofenac Potassium Paracetamol Chlorzoxazone Excipients Approved color used |
BP IP USP | 50mg 325mg 250mg q.s. |
| 481 | Sodium Valproate & Valproic Acid Controlled Release Tablets | Each film coated controled release tablet contains: Sodium Valproate Valproic Acid (Both together corresponds to Sodium Valproate 300mg) Excipients |
IP IP |
133mg 58mg q.s. |
| 482 | Saxagliptin Tablets | Each film Coated tablet contains: Saxagliptin Hydrochloride Eq. to Saxagliptin Excipients Approved color used |
IP | 5mg q.s. |
| 483 | Saxagliptin Tablets | Each film coated tablet contains: Saxagliptin Hydrochloride Eq. to Saxagliptin Excipients Approved color used |
IP | 2.5mg q.s. |
| 484 | Saxagliptin & Metformin Hydrochloride(ER) Tablets | Each film coated tablet contains: Saxagliptin Hydrochloride Eq. to Saxagliptin Metformin Hydrochloride (As extended Release) Excipients Approved color used |
IP IP |
5mg 500mg q.s. |
| 485 | Saxagliptin & Metformin Hydrochloride(ER) Tablets | Each film coated tablet contains: Saxagliptin Hydrochloride Eq. to saxagliptin Metformin Hydrochloride (As extended release) Excipients Approved color used |
IP IP |
5mg 1000mg q.s. |
| 486 | Saxagliptin & Metformin Hydrochloride(ER) Tablets | Each film coated tablet contains: Saxagliptin Hydrochloride Eq. to saxagliptin Metformin Hydrochloride (As extended release) Excipients Approved color used |
IP IP |
2.5.mg 500mg q.s. |
| 487 | Saxagliptin & Metformin Hydrochloride(ER) Tablets | Each film coated tablet contains: Saxagliptin Hydrochloride Eq.to Saxagliptin Metformin Hydrochloride (As extended release) Excipients Approved color used |
IP IP |
2.5mg 1000mg q.s. |
| 488 | Aceclofenac, Paracetamol & Chlorzoxazone | Each film coated tablet contains: Acecclofenac Paracetamol Chlorzoxzone Excipents Approved color used |
IP IP USP |
100mg 325mg 250mg q.s. |
| 489 | Venlafaxine Hydrochloride Tablets | Each uncoated tablet contains: Venlazaxine Hydrochloride Eq. to Venlafxine Excipients Approved color used |
USP | 25mg q.s |
| 490 | Venlafaxine Hydrochloride Tablets | Each uncoated tablet contains: Venlazaxine Hydrochloride Eq. to Venlafxine Excipients Approved color used |
USP | 37.5mg q.s. |
| 491 | Venlafaxine Hydrochloride Tablets | Each uncoated tablet contains: Venlafaxine Hydrochloride Eq. to Venlafaxine Excipients Approved color used |
USP | 75mg q.s. |
| 492 | Desvenlafaxine Extended Release Tablets 50mg | Each uncoated extended release tablet Contains: Desvenlafaxine Succinate Eq. to Desvenlafaxine Excipients Approved color used |
50mg q.s. | |
| 493 | Desvenlafaxine Extended Release Tablets 50mg | Each uncoatedEach uncoated extended release tablet Contains: Desvenlafaxine Succinate Eq. to Desvenlafaxine Excipients Approved color used |
100mg q.s. | |
| 494 | Deflazacort Tablets IP | Each uncoated tablet contains: Deflazacort Excipients Approved color used |
IP | 18mg q.s. |
| 495 | Spironolactone Tablets IP | Each uncoated tablet contains: Spironolactone Excipients Approved color used |
IP | 100mg q.s. |
| 496 | Spironolactone Tablets IP | Each uncoated tablet contains: Spironolactone Excipients Approved color used |
IP | 25mg q.s |
| 497 | Spironolactone Tablets IP | Each uncoted table contians: Spironolactone Excipients Approved color used |
IP | 25mg q.s |
| 498 | Spironolactone Tablets IP | Each uncoated tablet contains: Spironolactone Excipients Approved color used |
IP | 50mg q.s. |
| 499 | Satranidazole Tablets | Each film coated tablet contains: Satranidazole Excipients Approved color used |
IP | 150mg q.s. |
| 500 | Satranidazole & Ofloxacin Tablets | Each film coated tablet contains: Satranidazole Ofloxacin Excipients Approved color used |
IP | 300mg 200mg q.s. |
| 501 | Cyproheptadine Tablets IP | Each uncoated tablet contains: Cyproheptadine Hydrochloride (Anhydrous) Excipients Approved color used |
IP | 4mg q.s. |
| 502 | Diacerein & Glucosamine Tablets | Each uncoated tablet contains: Diacerin Glucosamine Sulphate Potassium Chloride Eq. to Glucosamine Excipients Approved color used |
IP USP | 50mg 500mg q.s. |
| 503 | Glucosamine Tablets USP | Each film coated tablet contains: Glucosamine Sulphate Potassium Chloride Eq. to Glucosamine Excipients Approved color used |
USP | 500mg 296mg q.s. |
| 504 | Enalapril Maleate Tablet IP | Each uncoated tablet contains: Enalapril Maleate Excipients Approved color used |
IP | 2.5mg q.s. |
| 505 | Enalapril Maleate Tablet IP | Each uncoated tablet contains: Enalapril Maleate Excipients Approved color used |
IP | 5mg q.s. |
| 506 | Mesalamine Prolong Release Tablets 1.2gm | Each enteric-coated tablet contans Mesalamine (As prolong release) Excipients Approved color used |
IP | 1.2mg q.s. |
| 507 | Pregabalin & Amitriptyline Hydrochloride Tablet | Each uncoated tablet contains: Pregabalin Amitriptyline Hydrochloride Excipients Approved color used |
IP IP |
75mg 10mg q.s. |
| 508 | Trihexyphenidyl Hydrochloride Tablets IP | Each uncoated tablet contains: Trihexyphenidyl Hydrochloride Excipients Approved color used |
2mg q.s. | |
| 509 | Glipizide & Metformin Hydrochloride Tablets | Each uncoated tablet contains: Glipizide (in beta cyclodextin) Metformin Hydrochloride Excipients Approved color used |
IP IP |
2.5mg 250mg q.s. |
| 510 | Glipizide & Metformin Hydrochloride Tablets | Each uncoated tablet contains: Glipizide (in beta cyclodextin) Metformin Hydrochloride Excipients Approved color used |
IP IP |
5mg 500mg q.s. |
| 511 | Glipizide Tablet IP | Each uncoate tablet contains: Glipizide Excipients Approved color used |
IP | 5mg q.s. |
| 512 | Glipizide Tablet IP | Each uncoate tablet contains: Glipizide Excipients Approved color used |
IP | 10mg q.s. |
| 513 | Warfarin Tablets IP | Each film coated tablet contains: Warfarin Sodium Excipients Approved color used |
USP | 5mg q.s. |
| 514 | Mirtazapine Tablets USP | Each film coated tablet contains: Mirtazapine (Anhydrous) Excipients Approved color used |
USP | 30mg q.s. |
| 515 | Mirtazapine Tablets USP | Each film coated tablet contains: Mirtazapine (Anhydrous) Excipients Approved color used |
USP | 45mg q.s. |
| 516 | Ondansetron & Ranitidine Tablets | Each film coated tablet contains: Ondanstron Hydrochloride Eq. to Ondansetron Ranitidine Hydrochloride Eq. to Ranitidine Excipients Approved color used |
IP IP |
4mg 150mg q.s. |
| 517 | Ebastine Tablets IP 10mg | Each film coated tablet contains: Ebastine Excipients Approved color used |
IP | 20mg q.s. |
| 518 | Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablets | Each extended-release tablet contains: Doxylamine Succinate Pyridoxine Hydrochloride Folic Acid Excipients Approved color used |
BP IP IP |
20mg 20mg 5mg q.s. |
| 519 | Diacerin & Aceclofenac Tablets | Each film coated tablet contains: Diacerin Aceclofenac Excipients Approved color used |
IP IP |
50mg 100mg q.s. |
| 520 | Donepezil Hydrochloride Tablets IP | Each film coated tablet contains: Donepezil Hydrochloride Excipients Approved color used |
IP | 5mg q.s. |
| 521 | Donepezil Hydrochloride Tablets IP | Each film coated tablet contains: Donepezil Hydrochloride Excipients Approved color used |
IP | 10mg q.s. |
| 522 | Ferrous Ascorbate, Folic Acid, Cyanocobalamin & Zinc Tablets | Each film coated tablet contains: Ferrous Ascorbate Eq. to Elemental Iron Folic Acid Zinc Sulphate Monohydrate Eq. to elemental Zinc Cyanocobalamin Excipients Approved color used |
IP IP IP |
100mg 1.5mg 61.8mg 22.5mg 15mg q.s. |
| 523 | Iron, Zinc, Folic Acid & Cyanocobalamin Tablets | Each film coated tablet contains: Ferrous Bis-Glycinate Eq. to Elemental Iron Zinc Bis-Glycinate Eq. to Elemental Zinc Folic Acid Cyanocobalamin Excipients Approved color used |
300mg 60mg 15mg 1mg 5mcg q.s. |
|
| 524 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each film coated tablet contains: Aceclofenac Paracetamol Chloroxazone Excipients Approved color used |
IP IP USP |
100mg 325mg 500mg q.s. |
| 525 | Sildenafil Citrate Tablets IP | Each film coated tablet contains: Sildenafil Citrate Eq. to Sildenafil excipients Approved Colour used |
IP | 25mg q.s |
| 526 | Telmisartan & Clinidipine Tablets | Each film coated tablet contains: Telmisartan Clinidipine Excipients Approved color used |
IP IP |
40mg 10mg q.s. |
| 527 | Ofloxacin, Ornidazole & Lactic Acid Bacillus Tablets | Each film coated tablet contains: Ofloxacin Ornidazole Lactic Acid Bacillus Excipients Approved color used |
IP IP |
200mg 500mg 60 Million Spores q.s. |
| 528 | Etamsylate & Citrus Bioflavonoid Tablets | Each film coated tablet contains: Etamsylate Citrus Bioflavonoid Excipients Approved color used |
BP | 250mg 150mg q.s. |
| 529 | Antioxidant, Multivitamin & Multimineral Tablets | Each film cated tablet contains: Vitamin A (As Acetate) Vitamin E (As Acetate) Ascorbic Acid (Coated) Thiamine Mononitrate Riboflavin Pyridoxine Hydrochloride Cyanocobalamin Niacinamide Folic Acid Calcium Pantothenate Zinc Oxide Eq. to elemental zinc Cupric Oxide Eq. to elemental Copper Sodium Selenate Eq. to elemental Selenium |
IP IP IP IP IP IP IP IP IP IP IP USP BP |
5000 IU 25I IU 100mg 10mg 10mg 3mg 5mcg 50mg 1mg 12.5mg 15mg 2.5mg |
| 530 | Eq. to elemental Selenium Manganese Chloride Eq. to elemental Manganese Chromium Chloride Eq. to elemental Chromium Excipients Approved color used |
USP USP | 60mcg 1.5mg 65mcg q.s |
|
| 531 | Doxycycline & Lactic Acid Bacillus Tablets | Each film coated tablet contains: Doxycycline Hydrochloride Eq. to Doxycycline Lactic Acid Bacillus Excipients Approved color used |
IP IP |
10mg 1500mcg q.s. |
| 532 | Amitriptyline Hydrochloride & Methylcobalamin Tablet | Each film coated tablet contains: Amitriptyline HCL Methylcobalamin Excipients Approved color |
IP IP |
10mg 1500mcg q.s. |
| 533 | Piroxicam-Betacyclodextrin Tablets | Each uncoated tablet contains: Piroxicam-Betacyclodextrin Eq. to Piroxicam Excipients Approved color used |
20mg q.s. | |
| 534 | Ilaprazole Tablets 5mg | Each enteric coated tablet contains: Ilaprazole Excipients Approved color used |
IP | 5mg q.s. |
| 535 | Ilaprazole Tablets 10mg | Each enteric coated tablet contains: Ilaprazole Excipients Approved color used |
IP | 10mg q.s. |
| 536 | Dapoxetine Hydrochloride Tablet | Each film coated tablet contains: Dapoxetine Hydrochloride Eq. to Dapoxetine Excipients Approved color used |
30mg q.s. | |
| 537 | Dapoxetine Hydrochloride Tablet | Each film coated tablet contains: Dapoxetine Hydrochloride Eq. to Dapoxetine Excipients Approved color used |
60mg q.s. | |
| 538 | Vinpocetine Tablet 5mg | Each uncoated tablet contains: Vinpocetine Excipients Approved color used |
BP | 5mg q.s. |
| 539 | Glucosamine Sulphate & Chondroitin Sulphate Tablets | Each film coated tablet contains: Glucosamine Sulphate (Added as Glucosamine Sulphate Sodium Chondroitin) Chondroitin Sulphate (Added as Glucosamine Sulphate Sodium) Excipients Approved color used |
IP | 500mg 400mg q.s. |
| 540 | Levetiracetam Tablets USP 1000mg | Each film coated talet contains: Levetiracetam Excipients Approved color used |
USP | 1000mg q.s. |
| 541 | Gabapentin & Nortriptyline Tablets | Each film coated tablet contains: Gabapentin Nortiptyline Hydrochloride Eq. to Nortriptyline Excipients Approved color used |
IP IP |
300mg 10mg q.s. |
| 542 | Pancretin & Activated Dimethicone Tablets | Each enteric coated tablet contains: Pancreatin Activated Dimethicone Excipients Approved color used |
IP IP |
170mg 80mg q.s. |
| 543 | Pregabalin Sustained Releae 75mg & Methylocobalamin 1500mcg Tablets | Each uncoated tablet contains: Pregabalin (As sustained release) Mecobalamin (Methylcobalamin) Excipients Approved color used |
IP IP |
75mg 1500mg q.s. |
| 544 | Pregabalin Sustained Releae 150mg & Methylocobalamin 1500mcg Tablets | Each uncoated tablet contains: Pregabalin (As sustained release) Mecobalamin (Methylcobalamin) Excipients Approved color used |
IP IP |
150mg 1500mg q.s. |
| 545 | Pregabalin Sustained Releae 300mg & Methylocobalamin 1500mcg Tablets | Each uncoated tablet contains: Pregabalin (As sustained release) Mecobalamin (Methylcobalamin) Excipients Approved color used |
IP IP |
300mg 1500mg q.s. |
| 546 | Methylcobalamin Orally Disintegrating Tablets 1500mcg | Each film coated tablet contains: Dried Extract of Ginkgo Biloba (contains 9.6mg of Ginkgo Flavone glycoside) Excipients Approved color used |
IP | 1500mg q.s. |
| 547 | Ginkgo Biloba Dry Extract Tablets USP | Each film coated tablet contains: Dried Extract of Ginkgo Biloba (Contains 9.6mg of Ginkgo Flavone Glycoside) Excipients Approved color used |
IP | 120mg q.s. |
| 548 | Duloxetine Delayed Release Tablets | Each entric coated delayed release tablet contains: Oxaceprol Excipients Approved color used in empty capsules shells |
200 mg q.s. |
|
| 549 | Duloxetine Delayed Release Tablets | Each enteric coated delayed release tablet contains: Duloxetine Hydrochloride Eq. to Duloxetine Excipients |
IP | 60mg q.s. |
| 550 | Omeprazole Magnesium Tablet 10mg | Each enteric coated tablet contains: Omeprazole Magnesium Eq. to Omeprazole Excipients Approved color used |
USP | 10mg q.s. |
| 551 | Omeraprazole Magnesium Tablet 20mg | Each enteric coated tablet contains: Omeprazole Magnesium Eq. to Omeprazole Excipients Approved color used |
USP | 20mg q.s. |
| 552 | Telemisartan & Clinidipine Tablets | Each film coated tablet contains: Telmisartan Clinidipine Excipients Approved color used |
IP IP |
80mg 10mg q.s. |
| 553 | Aceclofenac & Dryotaverine Hydrochloride Tablets | Each film coated tablet contains: Aceclofenac Drotaverine Hydrochloride Excipients Approved color used |
IP IP |
100mg 80mg q.s. |
| 554 | Paracetamol & Domperidone Tablets | Each uncoated tablet contains: Paracetamol Domperidone Maleate Excipients Approved color used |
IP IP |
500mg 20mg q.s. |
| 555 | Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets | Each film coated tablet contains: Diclofenac Potassium Paracetamol Serratiopeptidase (as enteric coated granules) Eq. to 20000 enzymatic units Excipients Approved color used |
BP IP IP |
50mg 325mg 10mg q.s. |
| 556 | Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets | Each film coated tablet contains: Diclofenac Potassium Paracetamol Serratiopeptidase (as enteric coated granules) Eq. to 20000 enzymatic units Excipients Approved color used |
BP IP IP |
50mg 325mg 10mg q.s. |
| 557 | Co-Enzyme Q10, Lycopente, Levocarnitine with Multi-Mineral tablets | Each film coated tablet contains: Ubidecarenone (Co-enzyme Q10) Levocarnitine Lycopene (Powder Form) Zinc Sulphate Monohydrate Eq. to elemental Zinc Elemental Selenium Excipients |
USP USP IP USP |
50mg 500mg 2.5mg 12.5mg 50mcg q.s. |
| 558 | Calcium Carbonate, Methylcobalamin Zinc, Magnesium, Vitamin K2-7 & Calcitriol Tablets | Each film coated tablet contains: Calcium Carbonate Eq. to Elemental Calcium Methylcobalamin Zinc sulphate monohydrate Eq. to elemental Zinc Magnesium Hydroxide Vitamin K2-7 Calcitriol Excipients Approved color used |
IP IP IP IP IP |
1250mg 500mg 1500mc g 22.5mg 7.5mg 50mg 45mg 0.25mc g q.s. |
| 559 | Ramipril Tablets IP | Each uncaoted tablet contains: Rammipril Excipients Approved color used |
IP | 1.25mg q.s. |
| 560 | Ramipril Tablets IP | Each uncaoted tablet contains: Rammipril Excipients Approved color used |
IP | 2.5mg q.s. |
| 561 | Ramipril Tablets IP | Each uncaoted tablet contains: Rammipril Excipients Approved color used |
IP | 5mg q.s. |
| 562 | Ramipril Tablets IP | Each uncaoted tablet contains: Rammipril Excipients Approved color used |
IP | 10mg q.s. |
| 563 | Losartan Potassium & Ramipril Tablets | Each film coated tablet contains: Losartan Potassium Ramipril Excipients Approved color |
IP IP |
50mg 2.5mg q.s. |
| 564 | Losartan Potassium & Ramipril Tablets | Each film coated tablet contains: Losartan Potassium Ramipril Excipients Approved color |
IP IP |
50mg 5mg q.s. |
| 565 | Actylcysteine Tablets | Each film coated tablet contains: Acetylcysteine Excipients Approved color used |
BP | 600mg q.s. |
| 566 | Carvedilol Tablets IP | Each film coated tablet contains: Carvedilol Excipients Approved color used |
IP | 3.125m g q.s. |
| 567 | Carvedilol Tablets IP | Each film coated tablet contains: Carvedilol Excipients Approved color used |
IP | 6.25mg q.s. |
| 568 | Carvedilol Tablets IP | Each film coated tablet contains: Carvedilol Excipients Approved color used |
IP | 12.5mg q.s. |
| 569 | Carvedilol Tablets IP | Each film coated tablet contains: Carvedilol Excipients Approved color used |
IP | 25mg q.s. |
| 570 | Pidotimod Tablets | Each film coated tablet contans: Pidotimod Excipients Approved color used |
400mg q.s. | |
| 571 | Pidotimod Tablets | Each film coated tablet contans: Pidotimod Excipients Approved color used |
800mg q.s. | |
| 572 | Orciprenaline Tablets BP 10mg | Each uncoated tablet contains: Orciprenaline Sulfate Excipients Approved color used |
BP | 10mg q.s. |
| 573 | Calcium, Magnesium, Zinc & Vitamin D3 Tablets | Each 5ml Contains: Calcium Carbonate Eq. to Magnesium Magnesium Hydroxide Eq. to Elemental Zinc Zinc Gluconate Eq. to Elemental Zinc Vitamin D3 Flavoured Syrupy Base Approved color used |
IP IP USP IP |
625mg 250mg 180mg 75mg 14mg 2mg 200 IU q.s. |
| 574 | Levocetirizine Hydrochhloride, Phenylephrine Hyrochloride & Paracetamol Tablets |
Each film coated tablet contains: Levocetirizine Hydrochloride Phenylephrine Hydrochloride Paracetamol Excipients Approved color used |
IP IP IP |
5mg 5mg 500mg q.s. |
| 575 | Sodium Picosulphate Tablets | Each uncoated tablet contains: Sodium Picosulphate Excipients Approved color ussed |
BP | 5mg q.s. |
| 576 | Sodium Picosulphate Tablets | Each uncoated tablet contains: Sodium Picosulphate Excipients Approved color ussed |
BP | 10mg q.s. |
| 577 | Hyoscine Butylbromide Tablets IP | Each film coated tablet contains: Hyoscine Butylbromide Excipients | IP | 10mg q.s. |
| 578 | Diclofenac Sodium, Paracetamol & Chlorzoxazone tablets | Each uncoated tablet contans: Diclofenac Sodium Paracetamol Chlorzoxazone Excipients Approved color used |
IP IP USP |
50mg 325mg 250mg q.s. |
| 579 | Diclofenac Sodium, Paracetamol & Chlorzoxazone tablets | Each uncoated tablet contans: Diclofenac Sodium Paracetamol Chlorzoxazone Excipients Approved color used |
IP IP USP |
50mg 325mg 500mg q.s. |
| 580 | Flupentixol & Melitracen Tablets | Each film coated tablet contans: Flupentixol Dihydrochloride Eq. to Melitracen Melitracen Hydrochloride Eq. to Melitracen Excipients Approved color used |
BP | 0.5mg 10mg q.s. |
| 581 | Chlorthalidone, Amlodipine & Telmisartan Tablets | Each film coated tablet contains: Chlorthalidone Amlodipine Besylate Eq. to Amlodipine Telmisartan Excipients Approved color used |
IP IP IP |
12.5 5mg 40mg q.s. |
| 582 | L-Ornithine L-Aspartate & Pancreatin Tablets | Each enteric coated tablet contains: L-Ornithine L-Aspartate Pancreatin Excipients Approved Color used |
IP | 150mg 100mg q.s. |
| 583 | Norfloxacin, Tinidazole & Lactic Acid Bacillus Tabltes | Each film coated tablet contains: Norfloxacin Tinidazole Lactic Acid Bacillus Excipients |
IP IP |
400mg 600mg 60million spores |
| 584 | L-Carnitine Tablets | Each film coated tablet contains: L-Carnitine L-Tartrate Eq. to L-Carnitine Excipients Approved color used |
500mg q.s. | |
| 585 | Valsartan Tablets IP 40mg | Each film coated tablet contains: Valsartan Excipients Approved color used |
IP | 40mg q.s. |
| 586 | Valsartan Tablets IP 80mg | Each film coated tablet contains: Valsartan Excipients Approved color used |
IP | 80mg q.s. |
| 587 | Valsartan Tablets IP 160mg | Each film coated tablet contains: Valsartan Excipients Approved color used |
IP | 160mg q.s. |
| 588 | Valsartan & Hydrochlorothizide Tablets | Each film coated tablet contains: Valsartnan Hydrochlorothiazide Excipients Approved color used |
IP IP |
80mg 12.5mg q.s. |
| 589 | Isosorbide Mononitrate Tablets IP 10mg | Each uncoated tablet contains: Diluted Isosorbide Mononitrate Eq. to Isosorbide Mononitrate Excipients Approved color used |
IP | 10mg q.s. |
| 590 | Isosorbide Mononitrate Tablets IP 20mg | Each uncoated tablet contains: Diluted Isorbide Mononitrate Eq. to Isosorbide Moninitrate Excipients Approved color used |
IP | 20mg q.s. |
| 591 | Mesalamine Delayed Release Tablet 800mg | Each delayed relase tablet contains: Mesalamine Excipients Approved color used |
IP | 800mg q.s. |
| 592 | Pantoprazole Tablets IP 20mg | Each enteric coated talet contans: Pantoprazole Sodium Sesquihydrate Eq. to Pantoprazole Excipients Approved color used |
IP | 10mg q.s. |
| 593 | Racecadotril Dispersible Tablet 10mg | Each uncoated dispersible tablet contains: Racecadotril Excipients Approved color used |
IP | 20mg q.s. |
| 594 | Nimesulide, Phenylephrine Hydrochloride, Cetirizine Dihydrochloride & Caffeine Tablet | Each film coated tablet contains: Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride Caffeine(Anhydrous) Excipients Approved color used |
IP IP IP IP |
100mg 10mg 5mg 30mg q.s. |
| 595 | Paracetamol, Levocetirizine Hydrochloride, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Caffeine Tablet | Each uncoated tablet contains: Paracetamol Levocetirizine Hydrochloride Dextromethorphan Hydrobromide Phenylephrine Hydrochloride Caffeine (Anhydrous) Excipients Approved color used |
IP IP IP IP IP |
325mg 5mg 5mg 5mg 30mg q.s. |
| 596 | Aceclofenac, Paracetamol, Paracetamol, Cetirizine, Phenylephrine Hydrochloride & Caffeine Tablets | Each uncaoted tablet contains: Aceclofenac Paracetamol Cetirizine Hydrochloride Phenylephrine Hydrochloride Caffeine (Anhydrous) Excipients Approved color used |
IP IP IP IP IP |
100mg 325mg 10mg 5mg 25mg q.s. |
| 597 | Bromhexine Hydrochloride, Guaiphenesin, Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Paracetamol Tablet | Each film coated tablet contains: Bromhexine Hydrochloride Gauiphhenesin Chlorpheniramine Maleate Phenylephrine Hydrochloride Paracetamol Excipients Approved color used |
IP IP IP IP IP |
4mg 50mg 4mg 5mg 325mg q.s. |
| 598 | Cetirizine Dihydrochloride, Phenylephrine Hydrochloride & Paracetamol Tablets | Each uncoated tablet contans: Cetirizine Dihydrochloride Phenylephrine Hydrochloride Paracetamol Excipients Approved color used |
IP IP IP |
5mg 10mg 325mg q.s. |
| 599 | Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Tablets | Each uncoated tablet contains: Paracetamol Phenylephrine Hydrochloride Caffeine Diphenhydramine Hydrochloride Excipients Approved color used |
IP IP IP IP |
325mg 5mg 30mg 25mg q.s. |
| 600 | Controlled release tablet of Sodium Valproate & Valproic Acid | Each film coated controlled release tablet contains: Sodium Valproate Valproic Acid (Both together corresponds to Sodium Valproate IP 500mg) Excipients Approved color used |
IP IP |
333mg 145mg |
| 601 | Indapamide Sustained Release Tablets IP 1.5mg | Each film coated tablet contains: Indapamide Excipients Approved color used |
IP | 1.5mg q.s. |
| 602 | Indapamide Sustained Release Tablets IP 2.5mg | Each film coated tablet contans: Indapamide Excipients Approved color used |
IP | 2.5mg q.s. |
| 603 | Mefloquine Hydrochloride Tablets | Each film coated tablet contans: Mefloquine Hydrochloride Eq. to Mefloquine Excipients Approved color used |
IP | 250mg q.s. |
| 604 | Nifedipine Sustained Release Tablets IP 20 mg | Each film coated sustained release tablet contains: Nifedipine Excipients Approved color used |
IP | 20mg q.s. |
| 605 | Nitrofurantoin Tablets IP 50mg | Each uncoated tablet contains: Nitrofurantoin Excipients Approved color used |
IP | 50mg q.s. |
| 606 | Sodium Valproate Tablet IP 100mg | Each enteric coated tablets contains: Sodium Valproate Excipients Approved color used |
IP | 100mg q.s. |
| 607 | Sodium Valproate Tablet IP 200mg | Each enteric coated tablets contains: Sodium Valproate Excipients Approved color used |
IP | 200mg q.s. |
| 608 | Sodium Bicarbonate Tablets 500mg | Each film coated tablet contains: Sodium Bicarbonate Excipients Approved color used |
IP | 500mg q.s. |
| 609 | Flupirtine Maleate & Paracetamol Tablets | Each uncoated tablet contains: Flupirtine Maleate Paracetamol Excipients Approved color used |
IP IP |
100mg 325mg q.s. |
| 610 | Vitamin E(Acetate) & Levocarnitine Tablets | Each film coated tablet contains: Tocopheryl Acetate (As 50% powder) L-Carnitne-Tartrate Eq. to Levocarnitine Excipients Approved color used |
IP USP |
200mg 150mg q.s. |
| 611 | Erythromycin Stearate Tablets IP 250mg | Each uncoated tablet contains: Erythromycn Stearate Eq. to Erythromycin Excipients Approved color used |
IP | 250mg q.s. |
| 612 | Erythromycin Stearate Tablets IP 500mg | Each uncoated tablet contains: Erythromycn Stearate Eq. to Erythromycin Excipients Approved color used |
IP | 500mg q.s. |
| 613 | Tolperisone Hydrochloride Sustained Release Tablets | Each sustained release film coated tablet contains: Tolperisone Hydrochloride Excipients Approved color used |
IP | 450mg q.s. |
| 614 | Tranexamic Acid Tablets IP 250mg | Each film coated tablet contains: Tranexamic Acid Excipients Approved color used |
IP | 250mg q.s. |
| 615 | Trimetazidine Hydrochloride Modified Release Tablets | Each film coated modified relese tablet contains: Trimetazidine Hydrochloride Excipients Approved color used |
BP | 35mg q.s. |
| 616 | Vinpocetine Tablets 5mg | Each uncoated tablet contains: Vinpocetine Excipients Approved color used |
IP | 5mg q.s. |
| 617 | Silymarin Tablets | Each film coated tablet contains: Silymarin Excipients Approved color used |
70mg q.s. | |
| 618 | Silymarin Tablets | Each film coated tablet contains: Silymarin Excipients Approved color used |
140 | |
| 619 | Solifenacin Succinate Tablets 5mg | Each film coated tablets contains: Solifenacin Succinate Excipients Approved color used |
BP | 5mg q.s. |
| 620 | Solifenacin Succinate Tablets 10mg | Each film coated tablets contains: Solifenacin Succinate Excipients Approved color used |
BP | 10mg q.s. |
| 621 | Sulfasalazine Deleyed Release Tablets USP 500mg | Each eneteric coated deleyed release tablet contains: Sulfasalazine Excipients Approved color used |
USP | 500mg q.s. |
| 622 | Nicoumalaone Tablets 1mg | Each uncoated tablet contains: Nicoumalone Excipients Approved color used |
IP | 1mg q.s. |
| 623 | Nicoumalaone Tablets 2mg | Each uncoated tablet contains: Nicoumalone Excipients Approved color used |
IP | 2mg q.s. |
| 624 | Nicoumalaone Tablets 3mg | Each uncoated tablet contains: Nicoumalone Excipients Approved color used |
IP | 3mg q.s. |
| 625 | Topiramate Tablets IP 50mg | Each film coated tablet contains: Topiramate Excipients Approved color used |
IP | 50mg q.s. |
| 626 | Etoricoxib Tablets IP 60mg | Each film coated tablet contains: Etoricoxib Excipients Approved color used |
IP | 60mg q.s. |
| 627 | Torsemide Tablet IP 5mg | Each uncoated tablet contans: Torsemide Excipients Approved color used |
IP | 5mg q.s. |
| 628 | Methylprednisoleone Tablets IP 2mg | Each uncoated tablet contains: Methylprednisolone Excipients Approved color used |
IP | 2mg q.s. |
| 629 | Nicoumalone Tablets IP 4mg | Each uncoated tablet contains: Nocoumalone Excipients Approved color used |
IP | 4mg q.s. |
| 630 | Itopride Hydrochloride Tablet 50mg | Each film coated tablet contains: Itopride Hydrochloride Excipients Approved color used |
IP | 50mg q.s. |
| 631 | Lisinopril Tablet IP 5mg | Each uncoated tablet contains: Lisinopril Excipients Approved color used |
IP | 5mg q.s. |
| 632 | Chlorampenicol Capsules 500 mg | Each hard gelatin capsule contains: Chloramphenicol Excipients Approved color used in empty Capsule shells |
IP | 500mg q.s. |
| 633 | Mefenamic Acid & Dicylomine Hydrochloride Tablets IP | Each uncoated tablet contains: Mefenamic Acid Dicyclomine Hydrochloride Excipients Approved color used |
IP IP |
500mg 20mg q.s. |
| 634 | Meloxicam Tablets IP 15 mg | Each uncoated tablet contains: Meloxicam Excipients Approved color used |
IP | 15mg q.s. |
| 635 | Mefloquine Tablets IP 250mg | Each uncoated tablet contains: Mefloquine Excipients Approvel color used |
IP | 250mg q.s. |
| 636 | Moxonidine Tablets 0.2mg | Each film coated tablet contains: Moxonidine Excipients Approved color used |
BP | 0.2mg q.s. |
| 637 | Moxonidine Tablets 0.3mg | Each film coated tablet contains: Moxonidine Excipients Approved color used |
BP | 0.3mg q.s. |
| 638 | Moxonidine Tablets 0.4mg | Each film coated tablet contains: Moxonidine Excipients Approved color used |
BP | 0.4mg q.s. |
| 639 | Oxcarbazepine Tablets 150mg | Each uncoated tablet contains: Oxcarbazepine Excipients Approved color used |
IP | 150mg q.s. |
| 640 | Oxcarbazepine Tablets 600mg | Each uncoated tablet contains: Oxcarbazepine Excipients Approved color used |
IP | 600mg q.s. |
| 641 | Diacerein Tablets IP 50mg | Each film coated tablet contains: Diacerin Excipients Approved color used |
IP | 50mg q.s. |
| 642 | Glimepride & Metformin Hydrochloride Prolong Release Tablets IP | Each film coated prolong release tablet contains: Glimepride Metformin Hydrochloride (As Prolong release) Excipientst Approved color used |
IP IP |
1mg 500mg q.s. |
| 643 | Glimepride & Metformin Hydrochloride Prolong Release Tablets IP | Each film coated prolong release tablet contains: Glimepride Metformin Hydrochloride (As Prolong release) Excipientst Approved color used |
IP IP |
2mg 500mg q.s. |
| 644 | Glimepride & Metformin Hydrochloride Prolong Release Tablets IP | Each film coated prolong release tablet contains: Glimepride Metformin Hydrochloride (As Prolong release) Excipientst Approved color used |
IP IP |
1mg 1000mg q.s. |
| 645 | Glimepride & Metformin Hydrochloride Prolong Release Tablets IP | Each film coated prolong release tablet contains: Glimepride Metformin Hydrochloride (As Prolong release) Excipientst Approved color used |
IP IP |
2mg 1000mg q.s. |
| 646 | Glimepride & Metformin Hydrochloride Sustained Release Tablets IP | Each uncoated bi-layered tablet contains: Glimepiride Metformin Hydrochloride (As sustained release) Excipients Approved color used |
IP IP |
3mg 500mg q.s. |
| 647 | Glimepride & Metformin Hydrochloride Sustained Release Tablets IP | Each uncoated bi-layered tablet contains: Glimepiride Metformin Hydrochloride (As sustained release) Excipients Approved color used |
IP IP |
4mg 500mg q.s. |
| 648 | Glimepride & Metformin Hydrochloride Sustained Release Tablets IP | Each uncoated bi-layered tablet contains: Glimepiride Metformin Hydrochloride (As sustained release) Excipients Approved color used |
IP IP |
3mg 1000mg q.s. |
| 649 | Glimepride & Metformin Hydrochloride Sustained Release Tablets IP | Each uncoated bi-layered tablet contains: Glimepiride Metformin Hydrochloride (As sustained release) Excipients Approved color used |
IP IP |
4mg 1000mg q.s. |
| 650 | Lansoprazole Orally Disintegrating Tablets | Each uncoated orally disintegrating tablet contains: Lansoprazole (As enteric coated pellets) Excipients Approved color used |
IP | 15mg q.s. |
| 651 | Trypsin-Chymotrypsin, Diclofenac Potassium & Paracetamol Tablets | Each enteric coated tablet contains: 1,00,000 Armour units of enzymatic activity supplied by a puriied concentrate which has speciic Trypsin & Chymotrypsin activity in a ratio o approximately six to one. Excipients Approved color used |
q.s. | |
| 652 | Aceclofenac, Paracetamol & Tizanidine Tablets | Each film coated tablet contains: Aceclofenac Paracetamol Tizanidine Excipients Approved color used |
IP IP IP |
100mg 325mg 2mg q.s. |
| 653 | Acarbose Tablet IP | Each uncoated tablet contains: Acarbose Excipients Approved color used |
IP | 25mg q.s. |
| 654 | Acarbose Tablet IP | Each uncoated tablet contains: Acarbose Excipients Approved color used |
IP | 50mg q.s. |
| 655 | Acarbose Tablet IP | Each uncoated tablet contains: Acarbose Excipients Approved color used |
IP | 100mg q.s. |
| 656 | Hyoscine Butylbromide Tablets IP 10mg | Each sugar coated tablet contains: Hyoscine Butylbromide Excipients Approved color used |
IP | 10mg q.s. |
| 657 | Hyoscine Butylbromide Tablets IP 20mg | Each sugar coated tablet contains: Hyoscine Butylbromide Excipients Approved color used |
IP | 20mg q.s. |
| 658 | Hyoscine Butylbromide & Paracetamol Tablets | Each film coated tablet contains: Hyoscine Butylbromide Paracetamole Excipients Approved color used |
IP IP |
10mg 500mg q.s. |
| 659 | Levocetirizine Hydrochloride, Amboxol Hydrochloride & Paracetamol Tablets | Each film coated tablet contains: Levocetirizine Hydrochloride Ambroxol Hydrochloride Paracetamol Excipients Approved color used |
IP IP IP |
5mg 30mg 325mg q.s. |
| 660 | Quetiapine Fumarate Tablets IP 25mg | Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved color |
IP | 25mg q.s. |
| 661 | Quetiapine Fumarate Tablets IP 50mg | Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved color |
IP | 50mg q.s. |
| 662 | Quetiapine Fumarate Tablets IP 100mg | Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved color |
IP | 100mg q.s. |
| 663 | Quetiapine Fumarate Tablets IP 200mg | Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved color |
IP | 200mg q.s. |
| 664 | Quetiapine Fumarate Tablets IP 300mg | Each film coated tablet contains: Quetiapine Fumarate Eq. to Quetiapine Excipients Approved color |
IP | 300mg q.s. |
| 665 | Glimepiride & Extended Release Metformin Hydrochloride Tablets | Each uncoated bi-layered tablet contains: Glimepiride Metformin Hydrochloride (As extended release) Excipients Approved color used |
IP IP |
0.5mg 500mg q.s. |
| 666 | Zinc Citrate, Vitamin C & Selenium Tablets | Each film cated tablet contains: Zinc (As Zinc Citrate) Vitamin C Selenium Excipients Approved color used |
IP IP IP |
2.2mg 500mg 60mcg q.s. |
| 667 | Vitamin C Tablets IP | Each uncoated tablet contains: Vitamin C (As Ascorbic Acid) Excipients Approved color used |
IP | 50mg q.s. |
| 668 | Vitamin C Tablets IP | Each uncoated tablet contains: Vitamin C (As Ascorbic Acid) Excipients Approved color used |
IP | 100 q.s |
| 669 | Vitamin C Tablets IP | Each uncoated tablet contains: Vitamin C (As Ascorbic Acid) Excipients Approved color used |
IP | 500mg q.s. |
| 670 | Zinc Acetate Tablet USP | Each enteric coated tablet contains: Zinc Acetate (As Dihydrate) Eq. to Elemental Zinc Excipients Approved color used |
USP | 167.86 mg 50mg q.s. |
| 671 | Zinc Gluconate, Ascoribic Acid & Sodium Ascorbate Chewable Tablets | Each chewable tablet contains Zinc Gluconate Eq. to Elemental Zinc Ascorbic Acid Sodium Ascorbic Acid Excipients Approved color used |
IP IP |
87.1mg 12.5mg 100mg 170mg 150mg q.s. |
| 672 | Zinc Sulphate Tablets USP | Each film coated tablet cotains: Zinc Sulphate Monohydrate Eq. to Elemental Zinc Excipients Approved color used |
IP | 150mg 54.6mg q.s. |
| 673 | Rivaroxaban Tablets | Each film coted tablet contains: Rivaroxaban Excipients Approved color used |
IP | 2.5mg q.s. |
| 674 | Rivaroxaban Tablets | Each film coted tablet contains: Rivaroxaban Excipients Approved color used |
IP | 10mg q.s. |
| 675 | Rivaroxaban Tablets | Each film coted tablet contains: Rivaroxaban Excipients Approved color used |
IP | 15mg q.s. |
| 676 | Rivaroxaban Tablets | Each film coted tablet contains: Rivaroxaban Excipients Approved color used |
IP | 20mg q.s. |
| 677 | Miglitol Tablet | Each film coted tablet contains: Miglitol Excipients Approved color used |
IP | 25mg q.s. |
| 678 | Miglitol Tablet | Each film coted tablet contains: Miglitol Excipients Approved color used |
IP | 50mg q.s. |
| 679 | Miglitol Tablet | Each film coted tablet contains: Miglitol Excipients Approved color used |
IP | 100mg q.s. |
| 680 | Miglitiol & Metformin Hydrochloride (SR) Tablets | Each uncoated bi-layered tablet contains: Miglitol Metformin Hydrochloride (As sustained release) Excipients Approved color used |
IP | 25mg 500mg q.s. |
| 681 | Miglitol & Metformin Hydrochloride (SR) Tablets | Each uncoated bi-layered tablet contains: Miglitol Metformin Hydrochloride (As sustained release) Excipients Approved color used |
IP | 50mg 500mg q.s. |
| 682 | Acetylcysteine Effervescent Tablets 600mg | Each effervescent tablet contains: Acetylcysteine Excipients Approved color used |
IP | 600mg q.s. |